|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2024―Okt―28 |
Permanent and persistent atrial fibrillation are independent risk factors of mortality after severe COVID-19 |
A Zajac, J D Kasprzak |
2 |
[GO] |
2024―Okt―28 |
Subclinical left ventricular dysfunction detected by speckle tracking echocardiography predicts mortality in COVID-19 patients |
E Cwiek-Rebowska, D Filipiak-Strzecka, K Cygulska, E Szymczyk, K Wdowiak-Okrojek, P Wejner-Mik, et al. (+3) D Miskowiec, J D Kasprzak, P Lipiec |
3 |
[GO] |
2024―Okt―28 |
Substantial morbidity and mortality due to cardiovascular diseases in hospitalized vaccinated and un-vaccinated patients with COVID-19 from 16 countries: the WHF COVID-19 Long-term study |
K Sliwa Hahnle, L Raspail, K Singh, K Nikhare, S Akter, S H Talukder, et al. (+8) T Kato, S Bertagnolio, J Rylance, A Banerjee, J Narula, D Pineiro, P Perel, D Prabhakaran |
4 |
[GO] |
2024―Okt―28 |
Vaccination status and long COVID symptoms among patients hospitalized with COVID-19: the WHF COVID-19 Long-term Study |
K Singh, D Prabhakaran, K Nikhare, L Raspail, A Banerjee, J Narula, et al. (+3) D Pineiro, P Perel, K Sliwa Hahnle |
5 |
[GO] |
2024―Okt―28 |
Effects of deferment of clinic visit on cardiovascular outcomes during COVID-19 outbreak: a prospective cohort study |
A Lai, K H Hui, B Yan, G M Tan |
6 |
[GO] |
2024―Okt―28 |
The effect of 2 years COVID-19 pandemic on myocardial infarction and stroke admissions: nationwide registry study, sex differences and mortality |
P Sedova, R D Brown, P Ostadal, M Vrablik, J Jarkovsky, M Lichter, et al. (+3) A Tichopad, R Mikulik, P Kala |
7 |
[GO] |
2024―Okt―28 |
Predictors of new-onset in-hospital atrial fibrillation in 122 089 patients admitted with COVID-19: an Australian statewide population study |
J Y A Ne, C Chow, V Chow, K Hyun, L Kritharides, D Brieger, A Ng |
8 |
[GO] |
2024―Okt―28 |
Predictors of B-line count in hospitalized patients with COVID-19 |
O Johannessen, C Espersen, E Platz, K G Skaarup, M C H Lassen, F S Davidovski, et al. (+9) J Christensen, JØ Simonsen, A B Nielsen, N D Johansen, M Sengeloev, K K Iversen, M Schou, P L Myhre, T B Sorensen |
9 |
[GO] |
2024―Okt―28 |
A systematic assessment of myocardial involvement and cardiovascular events up to six months in patients hospitalised with COVID-19 |
N Wilmes, F W Asselbergs, J J N Daems, H T Jorstad, R G Tieleman, C Ghossein-Doha, M Linschoten |
10 |
[GO] |
2024―Okt―28 |
Association of COVID-19 and influenza vaccinations and cardiovascular drugs with hospitalisation and mortality in COVID-19 and Long COVID: 2-year follow-up of 17 million individuals in England |
A Dashtban, M Mizani, S Rafferty, L Pasea, C Tomlinson, Y Mu, et al. (+7) N Islam, C Warren-Gash, S Denaxas, S Petersen, C Sudlow, K Khunti, A Banerjee |
11 |
[GO] |
2024―Okt―28 |
The incidence of cardiovascular conditions in patients admitted to hospital with and without COVID-19 in the South-East of Scotland |
A Bularga, F Gruber, I Lyell, D Kimenai, A Anand, K Pollock, et al. (+2) S Sandler, N Mills |
12 |
[GO] |
2024―Okt―28 |
Cardiopulmonary long-term effects 6, 18 and 30 months after severe COVID-19 infection |
J H Niebauer, A Iscel, S Schedl, S Charwat-Resl, C Capelle, M Kahr, et al. (+9) S Schamilow, M Srdits, J Faltas, M Lichtenauer, A Zoufaly, R Valenta, C Krestan, C Wenisch, D Bonderman |
13 |
[GO] |
2024―Okt―28 |
False-positive cardiac troponin I values in healthy athletes post COVID-19 Infection: concerning insights from a prospective cohort study |
E Kaplan, C K Kissel, L Bernasconi, P Lopez-Ayala, S Wittfooth, P Neyer, et al. (+8) G Hure, A Sanzone, R Manka, P Noack, D Hof, O Hammarsten, A Hammerer-Lercher, C Mueller |
14 |
[GO] |
2024―Okt―28 |
Effect of COVID-19 pandemic on the management of hypertension and the prevalence of lifestyle disease |
T Isogaki, H Takase, N Kawakatsu, K Hayashi, F Kin, Y Dohi |
15 |
[GO] |
2024―Okt―28 |
The role of cardiopulmonary rehabilitation in the recovery of right ventricular function and right ventricular-pulmonary artery coupling in convalescent COVID-19 patients |
M I Gounaridi, A Vontetsianos, N Chynkiamis, P Theofilis, A Anastasiou, I Tzima, et al. (+8) G Zakynthinos, I Gialamas, A Goliopoulou, K Kalogeras, M Vavouranakis, N Koulouris, E Oikonomou, G Siasos |
16 |
[GO] |
2024―Okt―28 |
How vaccination affects clinical outcomes of COVID-19 positive revascularized patients? |
O Musayev, R Dashdemirov, F Ibrahimov, G Dadashova, S H Shahbazova, Z Alimli, et al. (+3) S Gasimzade, N Mushtagzadeh, F Aliyeva |
17 |
[GO] |
2024―Okt―28 |
Patients vaccinated against COVID-19 present better coronary flow, myocardial work and NTproNP levels than non-vaccinated at 4 months post COVID infection |
I Ikonomidis, A Kountouri, K Katogiannis, G Pavlidis, J Thymis, G Kostelli, et al. (+8) E Katsanaki, K Thomas, A Antoniadou, S Tsiodras, A Frogoudaki, A R Vrettou, J Parissis, V Lambadiari |
18 |
[GO] |
2024―Okt―28 |
COVID-19 vaccine associated myocarditis in Norway - a nationwide validation study |
B Skinningsrud, K Vlaisavljevic, L S Oppedal, J Endresen, V Mohn, K Fladseth, et al. (+9) T M Lysaker, J Dahl, H L Gulseth, D B Olsen, M Ribe, M E Estensen, K Broch, K H Haugaa, N E Hasselberg |
19 |
[GO] |
2024―Okt―28 |
Safety of COVID-19 vaccines regarding cardiovascular events: a systematic review and meta-analysis |
A Ramandi, A H Behnoush, I Khaheshi |
20 |
[GO] |
2024―Okt―28 |
Incidence, patient characteristics, and treatment patterns of U.S. active-duty service members diagnosed with COVID-19-associated VTE in the outpatient setting |
J Pearman, F Kelly, G Kobakhidze, Z Ganesh, A Mcquistan, E Fentanes |
21 |
[GO] |
2024―Okt―28 |
Types of pulmonary hypertension and prognosis in COVID-19: 18-months analysis of BNP-PL national database |
A Mamzer, M Waligora, M Kurzyna, E Mroczek, T Mularek-Kubzdela, P Pruszczyk, et al. (+9) M Gasior, E Lewicka, D Karasek, B Kusmierczyk-Droszcz, K Mizia-Stec, K Ptaszynska, W Jachec, G Kopec, J D Kasprzak |
22 |
[GO] |
2024―Okt―28 |
Epidemiological, clinical, paraclinical, evolutionary, and therapeutic aspects of hypertensive patients infected by COVID-19: about 702 patients in our city |
A A Ngaide, L Fortes, I Wade, N D Gaye, J S Mingou, M Dioum, A Kane |
23 |
[GO] |
2024―Okt―28 |
ChineseCVD: a web-based Chinese-specifi c cardiovascular risk calculator incorporating long COVID, COVID-19vaccination, SGLT2i and PCSK9i treatment effects |
Q Lee, C Chang, G Tse, O H I Chou, T T L Lee, B K H Leung, et al. (+7) A N Lee, A Khan, W T Wong, A K C Wai, K Chen, T Liu, J Zhou |
24 |
[GO] |
2024―Okt―28 |
The relationship of clinical presentation, d-dimer levels and previous SARS-CoV-2 positivity in outpatients with suspected pulmonary embolism |
I Stankovic, N Milovanovic, K Grujicic, I Vranic, N Janeski, A N Neskovic |
25 |
[GO] |
2024―Jul―12 |
Thrombotic risks associated with COVID-19 vaccination in atrial fibrillation or atrial flutter: no reason for alarm |
Jean M Connors |
26 |
[GO] |
2024―Jul―12 |
Thromboembolism after coronavirus disease 2019 vaccination in atrial fibrillation/flutter: a self-controlled case series study |
You-Jung Choi, Jaehyun Lim, Sungho Bea, Jieun Lee, Jah Yeon Choi, Seung Young Rho, et al. (+3) Dae-In Lee, Jin Oh Na, Hyung-Kwan Kim |
27 |
[GO] |
2024―Jun―11 |
Pulmonary artery pseudoaneurysm due to COVID-19-associated pulmonary mucormycosis |
Zihao Li, Hongwei Zhang, Zhenhe Liu |
28 |
[GO] |
2024―Mrz―26 |
Third time’s a harm? Cardiac risk of SARS-CoV-2 mRNA booster vaccines in younger men |
Leslie T Cooper, Tal Hasin, Margaret Ryan |
29 |
[GO] |
2024―Feb―17 |
Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults: a Nordic cohort study |
Anders Hviid, Tuomo A Nieminen, Nicklas Pihlström, Nina Gunnes, Jesper Dahl, Øystein Karlstad, et al. (+6) Hanne Løvdal Gulseth, Anders Sundström, Anders Husby, Jørgen Vinsløv Hansen, Rickard Ljung, Petteri Hovi |
30 |
[GO] |
2023―Nov―22 |
New insights on the mechanisms of myocardial injury in hypertensive patients with COVID-19 |
R Moll Bernardes, J R Ferreira, A S Sousa, E B Schaustz, M B Tortelly, A L Pimentel, et al. (+9) A C B S Figueiredo, M M Noya-Rabelo, S Fortier, D C Albuquerque, P H Rosado De-Castro, G C Camargo, O F Souza, R R Luiz, E Medei |
31 |
[GO] |
2023―Nov―22 |
Examining the effect of COVID-19 on hypertrophic cardiomyopathy hospitalizations in the USA: a nationwide propensity-score matched analysis |
R Desai, A Srivastava, M Gandhi, A Perera, D Modi, M K Bellamkonda, et al. (+4) P Sunkara, A Nanjundappa, V Akki Vivekananand, S Singh |
32 |
[GO] |
2023―Nov―22 |
The impact of Covid-19 on mortality and clinical characteristics in hospitalized patients with peripheral artery disease in the year 2020 |
S Piepenburg, M Maslarska, K Kaier, C Von Zur Muehlen, D Westermann, C Hehrlein |
33 |
[GO] |
2023―Nov―22 |
Protecting the vulnerable during a crisis - TAVR during the COVID-19 pandemic |
A Zaka, N Mridha, J Abtahi, S Anderson, D Murdoch |
34 |
[GO] |
2023―Nov―22 |
The COVID-19 pandemic and reduced surgical site infection following cardiac surgery: time to take up the baton |
M Jameie, S Ilkhani, M Pashang, A Bagheri, A Jalali, K H Barkhordari, et al. (+5) M Nosrati, M Boroumand, K Hosseini, F Masoudkabir, J Bagheri |
35 |
[GO] |
2023―Nov―22 |
Cardiovascular risk and the COVID-19 pandemic: a retrospective observational study in a population of healthcare professionals |
G Solfanelli, A Tropea, D Giaccio, V Bucicovschi, G Gallo, G Tocci, et al. (+5) M B Musumeci, L Marcellini, E Barbato, M Volpe, A Battistoni |
36 |
[GO] |
2023―Nov―22 |
Specific therapies of pulmonary hypertension and prognosis in COVID-19: 18-months analysis of BNP-PL national database |
A Mamzer, M Waligora, M Kurzyna, E Mroczek, T Mularek-Kubzdela, P Pruszczyk, et al. (+9) I Skoczylas, E Lewicka, D Karasek, B Kusmierczyk-Droszcz, K Mizia-Stec, K Ptaszynska-Kopczynska, W Jachec, G Kopec, J D Kasprzak |
37 |
[GO] |
2023―Nov―22 |
Adjudicated thrombotic events in a cotemporary multicenter cohort of patients with COVID-19: findings from the CORONA-VTE Registry |
B Bikdeli, A Bejjani, C D Khairani, D Krishnathasan, A Armero, J Davies, et al. (+9) A Assi, U Campia, Z Almarzooq, J Welker, A Sharma, B Carroll, Z Lan, S Goldhaber, G Piazza |
38 |
[GO] |
2023―Nov―22 |
Effect of arterial hypertension in cardiopulmonary status and right ventricle function after hospitalization for Sars-Cov-2 |
M Kariori, C Fragoulis, C Chrysochoou, D Konstantinidis, I Leontsinis, I Andrikou, et al. (+8) P Iliakis, E Mantzouranis, K Konstantinou, T Kalos, K Grigoriou, C Aggeli, C Thomopoulos, K Tsioufis |
39 |
[GO] |
2023―Nov―21 |
Fighting the pandemic of heart failure: better utilization of current treatments, new drugs, and new therapeutic targets |
Filippo Crea |
40 |
[GO] |
2023―Nov―11 |
Speckle tracking echocardiography detects subtle right ventricular systolic dysfunction in post Covid syndrome after mild severity Covid-19 |
A Salem, H Kamel, A Shabana |
41 |
[GO] |
2023―Nov―11 |
Individual tailored physical training in patients with postural orthostatic tachycardia syndrome after COVID-19 - a feasibility study |
A Svensson, A Svensson-Raskh, M Stahlberg, J Bruchfeld, L Holmstroem, A Fedorowski, M Nygren-Bonnier |
42 |
[GO] |
2023―Nov―11 |
Comparing the effect of obesity on major adverse cardiovascular events in patients hospitalized with coronavirus disease-2019 (COVID-19): insights from the national inpatient sample (NIS) database |
E Gwira-Tamattey, R Gajjar, S Deangelo, S Shoura, N Nissan, I Asemota |
43 |
[GO] |
2023―Nov―11 |
Heatwaves and cardiovascular emergencies in our city, in Italy: pre-Covid-19, Covid-19 and post-Covid-19 characteristics and associated risk during heat days |
J Nawaro, L Gianquintieri, A Pagliosa, G M Sechi, E G Caiani |
44 |
[GO] |
2023―Nov―11 |
Lower incidence of new-onset heart disease following covid-19 compared to viral pneumonia despite more echocardiography |
T Ovrebotten, B Tholin, P L Myhre, K Stavem |
45 |
[GO] |
2023―Nov―11 |
Insights regarding in-hospital outcomes of COVID-19 hospitalisations and co-existing premature ventricular contractions : from national inpatient sample 2020 |
R Gajjar, T Teaima, N Battikh, I Aziz, S Shoura, Z Sad Aldeen |
46 |
[GO] |
2023―Nov―11 |
Incidence and risk factors of myocarditis in hospitalized patients with COVID-19 in Germany |
K Keller, I Sagoschen, S Konstantinides, T Gori, T Munzel, L Hobohm |
47 |
[GO] |
2023―Nov―11 |
Cardiopulmonary long-term impairment in patients 6 and 18 months post severe Covid-19 infection |
J H Niebauer, A Iscel, S Schedl, C Capelle, M Kahr, S Schamilow, et al. (+9) R Badr-Eslam, M Lichtenauer, A Zoufaly, R Valenta, S Charwat-Resl, C Krestan, W Hitzl, C Wenisch, D Bonderman |
48 |
[GO] |
2023―Nov―11 |
Pro-inflammatory sensitization of platelets after a mild course of COVID-19 infection |
C Tolksdorf, E Moritz, A Hafkemeyer, K Lehmann, K Becker, T Thiele, et al. (+6) E Schwedhelm, M Von Lucadou, M V Tzvetkov, S Engeli, G Jedlitschky, B H Rauch |
49 |
[GO] |
2023―Nov―11 |
Late gadolinium enhancement following Covid-19 infection does not predict outcome: a single-centre study |
K Vimalesvaran, J P Howard, S Zaman, B Ariff, A A Bharath, G Cole |
50 |
[GO] |
2023―Nov―11 |
Prior COVID-19 infection is associated with persistent and higher thrombus burden in acute coronary syndromes |
B To-Dang, M Zuckerman, S Cannata, R Roy, R Dalton, A Cannata, et al. (+7) I Webb, N Melikian, J Byrne, P Maccarthy, A J A Y Shah, R Dworakowski, N Pareek |
51 |
[GO] |
2023―Nov―11 |
Quantitative autonomic testing after recovery from acute COVID-19 infection: comparison with findings in controls and individuals with neurogenic autonomic dysfunction |
L Mascarenhas, R Kohno, D Mcdonald, S Colburn, D Benditt |
52 |
[GO] |
2023―Nov―11 |
Postural orthostatic tachycardia syndrome (POTS) and other autonomic dysfunction following COVID-19 infection: incidence, characteristic and associating factors |
C Tanking, C Lakkananurak, C Srisakvarakul, S Panda, A Jitpreeda, N Leethananirawit, et al. (+3) P Punprame, K Threechod, D Sukitpunyaroj |
53 |
[GO] |
2023―Nov―11 |
Reduction in acute coronary events without excess out of hospital cardiac arrest during the COVID-19 lockdown of 2020 in new South Wales, Australia |
S Fathieh, C Madronio, S Faddy, K Negishi |
54 |
[GO] |
2023―Nov―11 |
Risk of myocarditis requiring hospitalization following Covid-19 mRNA booster vaccinations |
R Arbel, M Yechezkel, E Shmueli, D Yamin |
55 |
[GO] |
2023―Nov―11 |
The COVID-19 mRNA vaccine Comirnaty induces anaphylactic shock in an anti-PEG hyperimmune large animal model |
B A Barta, T Radovits, A B Dobos, G T Kozma, T Meszaros, P Berenyi, et al. (+3) R Facsko, B Merkely, J Szebeni |
56 |
[GO] |
2023―Nov―11 |
A novel model in primary prevention for coronary artery disease amid the covid-19 pandemic |
O Soran, P Gunel, D Ozveri, M Yazdic, A Kaya, N Acar, et al. (+3) G Sofuoglu, H İ Deniz, B Zatari |
57 |
[GO] |
2023―Nov―11 |
Mortality after cardiovascular surgery and percutaneous coronary intervention prior to versus during the COVID-19 pandemic |
A Chu, X Wang, J M Paterson, M Hillmer, K Malikov, D S Lee |
58 |
[GO] |
2023―Nov―11 |
Did COVID-19 pandemic affect deaths from cardiovascular diseases in Japan? |
M Kokubo, A Shimizu, T Kamihara, A Hirashiki, H Arai |
59 |
[GO] |
2023―Nov―11 |
Impact of COVID-19 pandemics on the incidence and mortality in Takotsubo syndrome: a report from Swedish Coronary Angiography and Angioplasty Registry |
E Omerovic, T Gudmundsson, B Redfors, O Angeras, P Petursson, A Rawshani, et al. (+9) O Frobert, J Alfredsson, C Ekenbeck, L Henareh, K Skoglund, C Ljungman, M Mohammad, T Jernberg, D Erlinge |
60 |
[GO] |
2023―Nov―11 |
Subclinical left ventricular dysfunction demonstrated by strain imaging echocardiography in moderate to severe COVID-19 patients (Delta variant, single center study) |
C W Wuttichaipradit, C T Yodwut, P Sukhum, K Hengrussamee, M Treesong, S Thiangtham, et al. (+2) B Samut, A Tunhasiriwet |
61 |
[GO] |
2023―Nov―11 |
The association between obesity and mortality in otherwise metabolically healthy COVID-19 patients with cardiac arrest: insights from a National Inpatient Sample in the US, 2020 |
S Singh, M Gandhi, A Srivastava, A Perera, M K Bellamkonda, D Modi, et al. (+4) P Sunkara, A Nanjundappa, V Akki Vivekananand, R Desai |
62 |
[GO] |
2023―Nov―11 |
Impact of pulmonary embolism on COVID-19 pneumonia hospitalizations: analysis of the national inpatient sample 2020 |
M Kodali, R Atluri |
63 |
[GO] |
2023―Nov―11 |
Multimodality imaging and immunophenotyping of COVID-19 related myocardial injury (the MIIC-MI Study) |
A Corovic, X Zhao, Y Huang, D Gopalan, J Harrison, S Chen, et al. (+9) N Savinykh Yarkoni, A Sage, N Sithole, M R Bennett, J H F Rudd, Z Mallat, T X Zhao, M Nus, J M Tarkin |
64 |
[GO] |
2023―Nov―11 |
Surviving critical COVID-19 requiring mechanical ventilation is associated with a high risk of cardiovascular events post discharge |
A Liliequist, P Nordberg, M Stahlberg, R Hofmann, P Svensson |
65 |
[GO] |
2023―Nov―11 |
No association between COVID-19 vaccination and sudden cardiac death |
E Paratz, D Stub, A La Gerche |
66 |
[GO] |
2023―Nov―11 |
Increased troponin I blood level and in-hospital outcome across successive COVID-19 waves |
P R Benchimol Barbosa |
67 |
[GO] |
2023―Nov―11 |
The frequency of arrhythmia in patients with palpitations who had COVID-19 with 24-hour holter compared to the control group |
K Korkmaz, C Tulunay Kaya, T S Tan Kurklu |
68 |
[GO] |
2023―Nov―11 |
Mortality, cardiovascular disease and long covid at 3 months in individuals hospitalized with covid-19- a whf study |
K Sliwa Hahnle, K Nikhare, K Singh, L Raspail, A Banerjee, F Pinto, et al. (+4) J Narula, D Pineiro, P Perel, D Prabhakaran |
69 |
[GO] |
2023―Nov―11 |
Arterial hypertension, chronic kidney and severe valvular heart disease predict worse outcome after postponing non-emergency cardiac interventions during the COVID-19-pandemic |
S Andress, D Felbel, A Mack, M Rattka, S D`Almeida, D Buckert, et al. (+3) W Rottbauer, A Imhof, T Stephan |
70 |
[GO] |
2023―Nov―11 |
Myocardial infarction mortality after COVID-19: a nationwide population-based cohort study |
K D Brodersen, S P Ulrichsen, S Soerup, L Pedersen, R W Thomsen, H T Soerensen, M Schmidt |
71 |
[GO] |
2023―Nov―11 |
Long-term risk of pulmonary embolism and deep venous thrombosis after COVID-19: a population-based cohort study |
H Sjoland, M Lindgren, T Toska, P O Hansson, K Glise Sandblad, L Bjorck, et al. (+3) C E Lundberg, M Adiels, A Rosengren |
72 |
[GO] |
2023―Nov―11 |
Impact of atrial fibrillation on mortality and non-fatal cardiovascular outcomes in 145 293 patients admitted with COVID-19: a statewide population-linkage study |
J Y A Ne, C Chow, A Yan, I Rubenis, S Virk, V Chow, et al. (+4) K Hyun, L Kritharides, D Brieger, A Ng |
73 |
[GO] |
2023―Nov―11 |
Myocarditis after vaccination against COVID-19: an umbrella review of systematic review and meta-analysis |
A Bouchlarhem, S Boulouiz, N Ismaili, N El Ouafi |
74 |
[GO] |
2023―Nov―11 |
Adjudicated cardiovascular events in a cotemporary multicenter cohort of patients with COVID-19: findings from the CORONA-VTE Registry |
B Bikdeli, D Krishnathasan, C D Khairani, A Bejjani, A Tristani, N Porio, et al. (+9) A Assi, U Campia, E Wei, B Tiu, J Hsia, A Vishnevsky, Z Lan, S Goldhaber, G Piazza |
75 |
[GO] |
2023―Nov―11 |
Clinical outcomes of cardiac devices in heart failure patients hospitalized with COVID-19: insights from the united states national inpatient database |
E Moras, K Gandhi, A Correa, K Mahmood |
76 |
[GO] |
2023―Nov―11 |
Risk of atrial tachycardias after covid-19: nationwide self-controlled cases series and matched cohort study |
I Katsoularis, O Fonseca Rodriguez, H Jerndal, S Kalucza, K Lindmark, A M Fors Connolly |
77 |
[GO] |
2023―Nov―11 |
Impact of different types of heart failure on coronavirus disease 2019 infection outcomes |
O Al-Taweel, A Gill, R Shao, T Wineinger, D Alkhatib, C Ahsan |
78 |
[GO] |
2023―Nov―11 |
Sequential activation of DNA viruses by the RNA virus SARS-CoV-2 in patients with long COVID syndrome |
M Gyongyosi, E Hasimbegovic, D Lukovic, K Zlabinger, A Spannbauer, E Samaha, et al. (+9) J Bergler-Klein, C Hengstenberg, P Mucher, H Haslacher, M Breuer, R Strassl, M Riesenhuber, C Nitsche, T A Zelniker |
79 |
[GO] |
2023―Nov―11 |
Symptom burden, coagulopathy and heart disease, and quality of life at baseline and after 1-year follow-up following acute SARS-CoV-2 infection in a community medicine setting |
R Colleran, H Rai, S Fitzgerald, L Mcgovern, R J Byrne, A Cradock, et al. (+9) R Lavery, J Bisset, S Mckeogh, G Cantwell, D O'ciardha, J Mcnulty, G Szeplaki, J P O'donnell, R A Byrne |
80 |
[GO] |
2023―Nov―11 |
Former SARS-CoV-2-Infection is related to decreased peak VO2 and exercise hyperten-sion in athletes |
K Keller, O Friedrich, J Treiber, A Quermann, B Friedmann-Bette |
81 |
[GO] |
2023―Nov―11 |
SARS-COV2 infection and heart failure an intricate link of mutual impact |
I Cabac-Pogorevici, V Revenco |
82 |
[GO] |
2023―Nov―11 |
Quality of care and long-term outcomes for patients admitted with heart failure across the pandemic. A nationwide study |
A Cannata, D Bromage, S Piper, S Hardman, J G F Cleland, T Mcdonagh |
83 |
[GO] |
2023―Nov―11 |
A hub-and-spoke model for cardiac ablations: utilising satellite units to tackle the challenges from the pandemic and beyond |
V G Lim, H He, T Lachlan, N Chandan, V Ashok, J Al-Sheikhli, et al. (+8) R Siang, A Ammar, W Foster, S Panikker, T Dhanjal, S Yusuf, K Patel, F Osman |
84 |
[GO] |
2023―Nov―11 |
Long COVID and its cardiovascular implications: a call to action |
Ziyad Al-Aly |
85 |
[GO] |
2023―Jul―14 |
Addressing the pandemic of atrial fibrillation: optimization of catheter ablation and new therapeutic targets |
Filippo Crea |
86 |
[GO] |
2023―Jun―09 |
Addressing the pandemic of heart failure: old and new therapeutic opportunities |
Filippo Crea |
87 |
[GO] |
2023―Jun―02 |
COVID-19 vaccination-related myocarditis: a Korean nationwide study |
Jae Yeong Cho, Kye Hun Kim, Nuri Lee, Soo Hyeon Cho, Seung Yun Kim, Eun Kyoung Kim, et al. (+9) Jae-Hyeong Park, Eui-Young Choi, Jin-Oh Choi, Hyukjin Park, Hyung Yoon Kim, Hyun Ju Yoon, Youngkeun Ahn, Myung Ho Jeong, Jeong Gwan Cho |
88 |
[GO] |
2023―Jan―25 |
Cardiovascular profile and electrocardiographic findings of hospitalized adult patients during the surge of delta and omicron variants of COVID-19 in a COVID-19 tertiary referral center |
P A O Alad, F E R Punzalan, E J B Llanes, J A M Aherrera, G G Gervacio, E B Reyes, J C Anonuevo |
89 |
[GO] |
2023―Jan―25 |
Cardiac rehabilitation results among patients who have undergone cardiac surgery after covid-19 infection |
N Lampus, T Ransun, A M Ambari, B Dwiputra, B Radi |
90 |
[GO] |
2023―Jan―25 |
An updated meta-analysis: The effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the mortality of hypertensive patients with confirmed COVID-19 infection |
M Manalili, J Dionisio |
91 |
[GO] |
2023―Jan―25 |
Cardiovascular Profile of patients with COVID-19 infection admitted at a tertiary hospital |
R Tugade, E Ongjoco, M Turalba, A Yabon, N Bisquera, L Gonzales, et al. (+3) D Maderazo, E Suguitan, A Santos |
92 |
[GO] |
2023―Jan―25 |
Incidence of myocarditis among patients recovered from COVID-19 infection identified using cardiac magnetic resonance imaging |
R Tugade, N Palileo, A Panelo, M Correa, D Leycano, C Pawhay, J Cosare-San Pedro |
93 |
[GO] |
2023―Jan―25 |
Vaccination status and knowledge of CPR do not affect medical students' decision to perform BLS during the COVID-19 pandemic |
A P Bantolo, R G A Naranjilla |
94 |
[GO] |
2023―Jan―25 |
Modified STEMI protocol for Primary PCI during COVID-19 Pandemic:Does it prolong Door-To-Balloon performance? |
A Y Putranto, T M Haykal Putra, W A Soedarsono |
95 |
[GO] |
2023―Jan―25 |
Arterial thromboembolism (ATE) and mortality among COVID-19 patients in the intensive care unit (ICU): prevalence and risk factors |
H Zulkifly, F Mansor, I Abdul Halim Zaki, L C Kiok, T Ravi, M Pathmanathan |
96 |
[GO] |
2023―Jan―25 |
Electrocardiographic predictors of disease severity, mortality, and advanced ventilatory support among hospitalized covid-19 patients: a two year single center retrospective, cohort study |
G Vista, M Vestal |
97 |
[GO] |
2023―Jan―25 |
Pathophysiologic mechanism for MYOcarditis in COVID-19 VAccinations ("MYOVAx" Study) |
J Y Tan, Y W Chia, M Chan, S L Lim, C Chin, J Yap, et al. (+9) A M Richards, Z W Teo, M R Amanullah, K H Peck, T L J Choo, H W Sim, B E Young, P Macary, K K Yeo |
98 |
[GO] |
2023―Jan―25 |
Perindopril Reduce SARS-COV-2 Spike-ACE2 Binding, ACE2 Overexpression and Cytokine Storm in Adipocyte Cell Infected with SARS-COV-2 |
M J Makhyan Jibril Al Farabi, H O Hanestya Oky Hermawan, P M H Primasitha Maharani Harsoyo, S G D Stavros George Drakos, I G R I Gde Rurus Suryawan, M A Meity Ardiana |
99 |
[GO] |
2023―Jan―25 |
Frequent need for apixaban dose adjustment for atrial fibrillation in an unselected acute medical admission population during the COVID 19 pandemic |
K K K Kyaw, I B Menown |
100 |
[GO] |
2023―Jan―25 |
Improving cardiovascular health behaviors through a comprehensive lifestyle intervention program during the pandemic in India |
P Chockalingam, S Rajeswari, J Shobika, R Anantharaman, M M Yusuf, G Sengottuvelu, V Chockalingam |
101 |
[GO] |
2022―Nov―15 |
dal-GenE was negative-not positive except for COVID-19 |
Allan D Sniderman |
102 |
[GO] |
2022―Okt―15 |
Autoantibodies against the cardiovascular protective BPIFB4 in hospitalized patients with COVID-19 |
E Ciaglia, F Montella, V Lopardo, R M Esposito, F Guarracino, G Spinetti, et al. (+8) A A Maciag, M Ciccarelli, C Vitale, S G Pellegrino, B Polverino, C Izzo, C Vecchione, A A Puca |
103 |
[GO] |
2022―Okt―15 |
The role of cardiac troponin-I as a prognostic tool for mortality in patients hospitalized with COVID-19 |
J Quintal, A P Candjondjo, R A Coelho, A R Piteira, J S Simoes, R Pereira, et al. (+9) D Noivo, A Reis, A Inacio, J M Farinha, A F Esteves, J S Ferreira, C Pohle, T Duarte, R Caria |
104 |
[GO] |
2022―Okt―15 |
The state of systolic and diastolic functions of the left ventricle and heart rate variability in patients with atrial fibrillation after infection of COVID-19 |
O S Sychov, O G Nesukay, O V Stasyshena, T V Getman, O V Sribna, O M Romanova, et al. (+2) O Y A Ilchyshyna, S I Deyak |
105 |
[GO] |
2022―Okt―15 |
Impaired heart rate variability one and six months post acute COVID-19 |
S Lampsas, E Oikonomou, N Souvaliotis, A Goliopoulou, G A Papamikroulis, A Anastasiou, et al. (+9) P Theofilis, G Zakynthinos, I Gialamas, P Pantelidis, M A Gounaridi, A Tsatsaragkou, G Siasos, D Tousoulis, M Vavuranakis |
106 |
[GO] |
2022―Okt―15 |
Incidence of atrial and ventricular arrhythmias in patients with CIEDs and COVID-19 |
A D Margulescu, D E Thomas, M Kakoudaki, H Cranch, J O'Dea, G Davies, et al. (+4) A Phillips, A S Green, P Rees, J P Barry |
107 |
[GO] |
2022―Okt―15 |
The impact of pre-existing chronic heart failure on the intensive care treatment and outcome of old intensive care patients suffering from COVID-19 |
R R Bruno, B Wernly, G Wolff, A Artigas, B B Pinto, J C Schefold, et al. (+9) D Kindgen-Milles, P H Baldia, M Kelm, M Beil, S Leaver, D W De Lange, B Guidet, H Flaatten, C Jung |
108 |
[GO] |
2022―Okt―15 |
Time-related aortic inflammatory response, as assessed with 18F-FDG PET/CT, in patients hospitalized with severely or critical COVID-19 |
E Solomou, D Terentes-Printzios, V Gardikioti, P Katsaounou, D Exarchos, D Economou, et al. (+9) G Christopoulou, A D Kalkinis, P Kafouris, A Antonopoulos, A Kotanidou, I Datseris, K Tsioufis, C D Anagnostopoulos, C Vlachopoulos |
109 |
[GO] |
2022―Okt―15 |
Thrombosis-related miR-16-5p predicts the disease severity in patients hospitalised for COVID-19 |
D Keshwani, C Eyileten, Z Wicik, A Nowak, D Jakubik, S N Simoes, et al. (+6) D C Martins-Jr, A Shahzadi, J Jarosz-Popek, M Wolska, J Siller-Matula, M Postula |
110 |
[GO] |
2022―Okt―15 |
Protective effects of COVID-19 vaccination on endothelial function of patients with COVID-19 |
S Lampsas, E Oikonomou, N Souvaliotis, G A Papamikroulis, T Lytra, S Sarantos, et al. (+9) V C Mystakidi, P Pantelidis, K Kalogeras, P Theofilis, A Tsatsaragkou, G Siasos, C Tsioufis, D Tousoulis, M Vavuranakis |
111 |
[GO] |
2022―Okt―15 |
Investigation of the effect of the angiotensin II type 2 receptor (AT2R) agonist C21 on plasma NT-proBNP, a diagnostic biomarker, in subjects hospitalised with COVID-19 |
R Batta, G Tornling, E Rosendahl, T Bengtsson, J Raud |
112 |
[GO] |
2022―Okt―15 |
Galectin-3 as a possible marker for increased thrombogenicity in COVID-19 |
M Puccini, K Jakobs, J Friebel, L Reinshagen, P A Schencke, A Haghikia, et al. (+3) U Landmesser, N Kraenkel, U Rauch |
113 |
[GO] |
2022―Okt―15 |
Parameters of coagulation and platelet hyperreactivity reflect an increased mortality in patients with moderate to severe COVID-19 |
K Jakobs, M Puccini, L Reinshagen, A A Alsheikh, J Friebel, U Lanmdesser, et al. (+3) A Haghikia, N Kraenkel, U Rauch |
114 |
[GO] |
2022―Okt―15 |
Predictors and clinical consequences of heart damage in CMR in patients after COVID-19 |
M Chudzik, D Miskowiec, J Kapusta, M Babicki, J D Kasprzak |
115 |
[GO] |
2022―Okt―15 |
The use of handheld ultrasound device in cardiac examination of patients with history of COVID-19 |
D Filipiak, J D Kasprzak, P Lipiec |
116 |
[GO] |
2022―Okt―15 |
The role of cardiometabolic risk factors and endothelial dysfunction in serum albumin levels and capillary leak syndrome of patients with COVID-19 |
E Oikonomou, S Lampsas, V Lampadiari, E Korakas, E Bletsa, N Souvaliotis, et al. (+9) P Theofilis, A Tsatsaragkou, G Poulakou, D Tsoukalas, P Pantelidis, S M Kyvelou, G Siasos, D Tousoulis, M Vavuranakis |
117 |
[GO] |
2022―Okt―15 |
Adults with congenital heart disease and COVID-19 |
N Langes, S J Maurer, C Meierhofer, N Nagdyman, F Bourier, S Holdenrieder, et al. (+2) P Ewert, O Tutarel |
118 |
[GO] |
2022―Okt―15 |
Cardiac injury before and after COVID-19. A longitudinal MRI study |
J E Gonzalez, A Doltra, R J Perea, P Lapena, C Garcia-Ribas, J Reventos, et al. (+9) G Caixal, J M Tolosana, E Guasch, I Roca-Luque, E Arbelo, M Sitges, S Prat, L Mont, T F Althoff |
119 |
[GO] |
2022―Okt―15 |
Dexamethasone improves cardiovascular outcomes in critically ill COVID-19, a real world scenario multicenter analysis |
P Jirak, V Van Almsick, D Dimitroulis, M Mirna, C Seelmaier, Z Shomanova, et al. (+9) D Semo, D Dankl, M Mahringer, M Lichtenauer, U Hoppe, H Reinecke, R Pistulli, R Larbig, L Motloch |
120 |
[GO] |
2022―Okt―15 |
COVID-19 and acute heart failure among patients with cancer |
M Bergami, N Fabin, P Mjehovic, M Pasalic, M Scarpone, Z Vasiljevic, et al. (+9) M Vavlukis, M L Vega Pittao, V Vukomanovic, G Mancuso, A David, G Caramori, S Nava, O Manfrini, R Bugiardini |
121 |
[GO] |
2022―Okt―15 |
COVID-19 and cardiovascular system: not only heart but also vascular. The effects of the infection on arterial stiffness |
A Maloberti, E Gualini, S Scarpellini, M Algeri, M Biolcati, E Grasso, et al. (+2) C Tognola, A Moreo |
122 |
[GO] |
2022―Okt―15 |
D-dimer-driven versus standard prophylactic anticoagulation with fondaparinux in critically ill patients with COVID-19 and coagulopathy: an open-label, randomized controlled trial |
L H Adrian, S A Hutomo, A D S Negari |
123 |
[GO] |
2022―Okt―15 |
Variables associated with bleeding and thrombotic outcomes among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomised clinical trial |
P G Barros E Silva, R D Lopes, R H M Furtado, A V S Macedo, B Bronhara, L P Damiani, et al. (+9) L M Barbosa, J A Morata, E Ramacciotti, P A Martins, A L De Oliveira, V S Nunes, L E F Ritt, A T Rocha, L Tramujas |
124 |
[GO] |
2022―Okt―15 |
COVID-19 and the autonomic nervous system |
R A Xuereb, R G Xuereb, C Barbara, S Fava, C J Magri |
125 |
[GO] |
2022―Okt―15 |
COVID-19 associated Brugada pattern electrocardiogram: systematic review of case reports |
K C Chen, A Z Rathore, T Deol, K L Liu, E W Wu, J S Su, et al. (+2) T W Wannenburg, J N C Catanzaro |
126 |
[GO] |
2022―Okt―15 |
Post COVID-19 cardiac magnetic resonance findings among inpatients vs outpatients |
M Klinceva, L V Veljanovska-Kiridzievska, P Z Zafirovska, E I Idoski, V A Ampova-Sokolov, T A Angjusheva, et al. (+4) I M Milev, S I Idrizi, I N Neshkovski, Z M Mitrev |
127 |
[GO] |
2022―Okt―15 |
Atherosclerosis licenses for an exceeding immune response in COVID-19 disease |
J Leberzammer, W T Abplanalp, S F Glaser, B Schumacher, M Merten, M T Katschke, et al. (+5) D John, M Vehreschild, A Zeiher, S Dimmeler, S Cremer |
128 |
[GO] |
2022―Okt―15 |
Expression changes of circulating ACE2 regulating-microRNA profiles in patients with COVID-19 during hospitalisation |
J Jarosz-Popek, C Eyileten, Z Wicik, A Nowak, M Wolska, A Shahzadi, et al. (+5) D Jakubik, S N Simoes, D C Martins, J Siller-Matula, M Postula |
129 |
[GO] |
2022―Okt―15 |
History of heart failure and chronic kidney disease and the risk for all-cause death after COVID-19 during the three first waves in comparison to influenza outbreaks in Sweden |
V Ritsinger, J Bodegard, R Kristofi, M Thuresson, D Nathanson, T Nystrom, et al. (+2) J W Eriksson, A Norhammar |
130 |
[GO] |
2022―Okt―15 |
The effect of smoking on exhaled carbon monoxide and arterial elasticity during prolonged surgical mask use in the COVID-19 era |
I Ikonomidis, K Katogiannis, K Kourea, G Kostelli, D Tsilivarakis, G Pavlidis, et al. (+6) J Thymis, E Michalopoulou, V Prentza, V Lambadiari, D Kouretas, G Biondi-Zoccai |
131 |
[GO] |
2022―Okt―15 |
Cardiovascular features and risk of mortality in COVID-19 hospitalized patients in Spain during 2020. A nationwide study from the Minimum Basic Data Set |
C Risco Risco, L Ayerbe Garcia-Monzon, P Villares Fernandez, A Martin Arnau, D Andaluz Ojeda |
132 |
[GO] |
2022―Okt―15 |
Trends and risk factors of in-hospital mortality of patients with COVID-19 in Germany |
K Keller, I Sagoschen, S Barco, I Schmidtmann, C Espinola-Klein, S Konstantinides, et al. (+2) T Munzel, L Hobohm |
133 |
[GO] |
2022―Okt―15 |
Cardiopulmonary long-term effects in patients after hospitalization due to COVID-19 infection |
J Niebauer, C Binder, A Iscel, S Klenk, C Capelle, M Kahr, et al. (+9) S Cadjo, M Lichtenauer, A Toma, A Zoufaly, S Hoffman, S Charwat-Resl, C Krestan, C Wenisch, D Bonderman |
134 |
[GO] |
2022―Okt―15 |
Anxiety and depression among ambulatory and hospitalized patients with cardiovascular long-COVID-19 presentation referred to cardiology consultation after COVID-19 infection |
P Rasmus, J D Kasprzak, M Chudzik, A Lipert |
135 |
[GO] |
2022―Okt―15 |
COVID-19 infection and its impact on case-fatality in patients with pulmonary embolism |
L Hobohm, I Sagoschen, S Barco, I Farmakis, U Fedeli, S Koelmel, et al. (+5) T Gori, C Espinola-Klein, T Munzel, S Konstantinides, K Keller |
136 |
[GO] |
2022―Okt―15 |
Coronary microvascular health in patients with prior COVID-19 infection and no known CAD |
A I Ahmed, J M Saad, Y Han, F Alahdab, M Malahfji, F Nabi, et al. (+4) J Mahmarian, J P Cooke, W A Zoghbi, M H Al-Mallah |
137 |
[GO] |
2022―Okt―15 |
Impaired endothelial glycocalyx, vascular dysfunction and myocardial deformation four months after COVID-19 infection are partially improved at twelve months |
I Ikonomidis, A Kountouri, A Mitrakou, K Katogiannis, J Thymis, E Korakas, et al. (+8) G Pavlidis, I Andreadou, C Chania, A Bamias, K Thomas, A Antoniadou, V Lambadiari, G Filippatos |
138 |
[GO] |
2022―Okt―15 |
Prevalence and diagnostic significance of novel 12-lead ECG patterns following COVID-19 infection in elite soccer players |
R Bhatia, A Malhotra, H MacLachlan, S Gati, A Kasiakogias, S Marwaha, et al. (+9) N Chatrath, S Fyyaz, R Cooper, D Rakhit, A Varnava, M Esteban, G Finocchiaro, M Papadakis, S Sharma |
139 |
[GO] |
2022―Okt―15 |
Effects of COVID-19 infection on ECG parameters in outpatients |
H Deniz, F Deniz |
140 |
[GO] |
2022―Okt―15 |
Assessment of cardiac involvement in patients recovered from corona virus disease-19 (COVID-19) infection using magnetic resonance imaging |
M Florentino, S Javier, S Sawit, V Geron, J De La Rosa, P Quetua, N Rosas |
141 |
[GO] |
2022―Okt―15 |
Risk of acute myocardial infarction, stroke and thromboembolism following COVID-19 vaccination compared to testing positive for COVID-19 infection: a nationwide cohort study of 4.6 mio individuals |
M H Lassen, D Modin, K G Skaarup, B Claggett, S D Solomon, M Fralick, et al. (+9) J U Staehr-Jensen, P Sivapalan, M Schou, T G Krause, A Hviid, L Koeber, C Torp-Pedersen, G Gislason, T Biering-Soerensen |
142 |
[GO] |
2022―Okt―15 |
Effects of lockdown on physical activity and arrhythmia burden in patients with an implantable cardioverter-defibrillator: the COVID-19 Lockdown ICD-Carelink (CLIC) study |
M A Ghossein, D Linz, D J W Van Kraaij, A M W Van Stipdonk, M De Melis, K Vernooy, J Heijman |
143 |
[GO] |
2022―Okt―15 |
Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality |
M Mohamed, A Banerjee, S Clarke, M De Belder, A Goodwin, C Gale, et al. (+2) N Curzen, M Mamas |
144 |
[GO] |
2022―Okt―15 |
Impact of COVID-19 on mechanical complications in ST elevation myocardial infarction |
N El Ouaddi, C Escabia, F Rueda, T Oliveras, S Montero, C Labata, et al. (+3) M Ferrer, C Garcia-Garcia, A Bayes-Genis |
145 |
[GO] |
2022―Okt―15 |
The effect of COVID-19 on training in cardiology: a survey of UK cardiology trainees |
C J F Camm, A R Chapman, T R Gilpin, M Westwood, J P Greenwood, A Calver, C J Allen |
146 |
[GO] |
2022―Okt―15 |
ECG abnormalities and their relation to COVID-19 outcomes - a WHF study |
M Martins Pinto Filho, G M M Paixao, C P M Soares, P R Gomes, L Raspail, V Rossi, et al. (+5) K Singh, P Perel, D Prabhakaran, K Sliwa-Hahnle, A L P Ribeiro |
147 |
[GO] |
2022―Okt―15 |
Clinical outcome of patients with severe malignant pericardial effusion due to neoplastic disease undergoing percutaneous balloon pericardiotomy during COVID-19 pandemic |
E Alfonso Rodriguez, G Lopez Cabrera, L L Llerena Rojas, L Rodriguez Nande, L Lopez Ferrero, J Echarte Martinez |
148 |
[GO] |
2022―Okt―15 |
Aggression, mini-aggression, and abuse against health care workers during the COVID-19 pandemic |
S Garcia-Zamora, L Pulido, M Antoniolli, D Garcia, G Perez, M Priotti, et al. (+9) E Zaidel, R Lopez-Santi, G Vazquez, D X Chango-Azanza, R Nunez-Mendez, L T Cabral, A Sosa-Liprandi, A F Miranda-Arboleda, A Baranchuk |
149 |
[GO] |
2022―Okt―15 |
Investigating monotherapy and combination therapy trends in newly diagnosed patients with pulmonary arterial hypertension among EU3 & UK physicians over the COVID-19 pandemic |
D Chandler, N Syarmimi, L Gill, N Allie |
150 |
[GO] |
2022―Okt―15 |
COVID-19 pandemic affects STEMI numbers and in-hospital mortality: results of a nationwide analysis in Germany |
V Oettinger, A Heidenreich, M Zehender, C Bode, P Stachon, K Kaier, C Von Zur Muehlen |
151 |
[GO] |
2022―Okt―15 |
A blueprint for the continuation of comprehensive cardiac rehabilitation during the COVID-19 pandemic. An Australian single hospital experience |
R Zecchin, C Dickson, J Hungerford, J Leow, G Lindsay, R Mander, et al. (+2) I Saliba, A R Denniss |
152 |
[GO] |
2022―Okt―15 |
COVID-19 pandemic and cardiovascular mortality and morbidity in the Czech Republic |
J Bruthans, J Rychtarikova, J Jarkovsky |
153 |
[GO] |
2022―Okt―15 |
Women in cardiology leadership of randomized clinical trials and participation of women in late-breaking clinical trials: has the COVID-19 pandemic changed a thing or not exactly? |
B Parapid, H Hachemi, F A Cader, M Alasnag, M Asanin, J Siller-Matula, et al. (+9) M Trofenciuc, R M Bond, R Waksman, R Kataria, J Katsa, A Mischie, J Milin Lazovic, V Kanjuh, N Kass Wenger |
154 |
[GO] |
2022―Okt―15 |
Effects of the COVID-19 pandemic on offering and acceptance in a cardiac rehabilitation programme: introduction of a remote CR programme |
M Sestayo Fernandez, M Alonso Vazquez, A Gonzalez Maestro, V Gonzalez Salvado, J R Gonzalez Juanatey, C Pena Gil |
155 |
[GO] |
2022―Okt―15 |
Impact of COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction |
Z Motovska, O Hlinomaz, M Hromadka, P Kala, A Klechova, J Precek, et al. (+7) J Kettner, J Mrozek, J Cervinka, J Matejka, A Zohor, J Bis, J Jarkosvky |
156 |
[GO] |
2022―Okt―15 |
Takostubo syndrome during the COVID-19 pandemic: a single center experience |
L Rallidis, D Iordanidis, N Kosmas, E Kiouri, K Papathanasiou, S Vlachos, G Filippatos |
157 |
[GO] |
2022―Okt―15 |
Mortality related to pulmonary embolism in the United States before and during the COVID-19 pandemic: an analysis of the CDC Multiple Cause of Death database |
I Farmakis, L Valerio, A C Mavromanoli, B Bikdeli, J M Connors, G Giannakoulas, et al. (+9) S Z Goldhaber, L Hobohm, B J Hunt, K Keller, F A Klok, A C Spyropoulos, N Kucher, S Konstantinides, S Barco |
158 |
[GO] |
2022―Okt―15 |
Impact of COVID-19 pandemics upon nationwide pulmonary hypertension cohort: 18-months analysis of BNP-PL national database |
A Mamzer, J D Kasprzak, M Waligora, M Kurzyna, E Mroczek, T Mularek-Kubzdela, et al. (+9) P Pruszczyk, E Lewicka, D Karasek, B Kusmierczyk-Droszcz, K Mizia-Stec, K Ptaszynska-Kopczynska, I Skoczylas, P Blaszczak, G Kopec |
159 |
[GO] |
2022―Okt―15 |
Evaluation of cardiovascular autonomic dysfunction in symptomatic post COVID-19 patients |
A M Noureldin, M Bassem, Z Abdelsalam |
160 |
[GO] |
2022―Okt―15 |
Admission serum magnesium levels associated with short- and long-term clinical outcomes in COVID-19 patients |
A Segev, A Sagir, S Matezky, A Segev, S Atar, M Shechter |
161 |
[GO] |
2022―Okt―15 |
Major adverse cardiac events in critically ill COVID-19 patients |
V Lopes, J P Baptista, N Moreira, L Goncalves |
162 |
[GO] |
2022―Okt―15 |
Impact of dexamethasone on cardiac injury in critically ill COVID-19 patients |
V Van Almsick, P Jirak, D Dimitroulis, M Mirna, C Seelmaier, Z Shomanova, et al. (+9) D Semo, D Dankl, M Mahringer, M Lichtenauer, U Hoppe, H Reinecke, R Larbig, L Motloch, R Pistulli |
163 |
[GO] |
2022―Okt―15 |
Atrial fibrillation in COVID-19 patients admitted to an intensive care unit: prevalence and prognosis |
V Lopes, J P Baptista, N Moreira, L Goncalves |
164 |
[GO] |
2022―Okt―15 |
Specific characteristics of STEMI in COVID-19 patients and their practical implications: a systematic review |
M Gitto, L Novelli, O Cozzi, B Reimers, G Condorelli, G G Stefanini |
165 |
[GO] |
2022―Okt―15 |
Outcomes of COVID-19 patients with STEMI undergoing primary PCI |
P Kleczynski, L Niewiara, A Kulbat, M Kaczynski, T Pawlowski, S Socha`, et al. (+4) T Rakowski, R Gil, S Bartus, J Legutko |
166 |
[GO] |
2022―Okt―15 |
Optimal thromboprophylaxis and anticoagulant strategies in patients with COVID-19 pneumonia. The PROTHROMCOVID Trial |
N Munoz-Rivas, J Aibar Gallizo, C Gabara-Xanco, A Trueba-Vicente, A Urbelz-Perez, V Gomez-Del Olmo, et al. (+9) P Demelo-Rodriguez, A Rivera-Gallego, P A U Bosch-Nicolau, J A Nieto Rodriguez, M Rios-Prego, O Madridano-Cobo, M Mendez, J A Hernandez-Rivas, J Torres-Macho |
167 |
[GO] |
2022―Okt―15 |
The effectiveness of a telemedical program for COVID-19 positive high-risk patients in domestic isolation |
L Brunelli, L Poelzl, J Hirsch, C Engler, F Naegele, T Egelseer-Bruendl, et al. (+7) T Scheffauer, C Rassel, C Schmit, F Nawabi, A Luckner-Hornischer, A Bauer, G Poelzl |
168 |
[GO] |
2022―Okt―15 |
Comparison of thrombus burden in patients with COVID-19 presenting with ST-segment elevation myocardial infarction across the three waves of outbreak in the United Kingdom |
Z Teoh, K Rathod, A Tyrlis, F Choudry, K Comer, O Guttmann, et al. (+6) A Jain, A Wragg, A Archbold, A Baumbach, A Mathur, D Jones |
169 |
[GO] |
2022―Okt―15 |
Long-term effects of coronavirus disease 2019 on the cardiovascular system: the CV COVID-19 registry |
V Arevalos Rivas, L Ortega-Paz, D Fernandez-Rodriguez, V A Jimenez-Diaz, J Baneras Rius, G Campo, et al. (+9) J F Diaz, C Scardino, M Rodriguez-Santamarta, N Gonzalo, A Perginotti, F Alfonso, I Amat-Santos, M Sabate, S Brugaletta |
170 |
[GO] |
2022―Okt―15 |
Long COVID-19 syndrome: association of cardiopulmonary impairment with a persistent platelet activation |
M Camera, M Brambilla, P Canzano, A Becchetti, M Conti, P G Agostoni, et al. (+6) M Pengo, E Tortorici, M E Mancini, D Andreini, A Bonomi, G F Parati |
171 |
[GO] |
2022―Okt―15 |
Blood pressure alterations in recently COVID-19 vaccinated patients |
E Sanidas, D Papadopoulos, T Anastasiou, M Velliou, E Michalaki, A Fotsali, et al. (+3) S Golemati, M Mantzourani, J Barbetseas |
172 |
[GO] |
2022―Okt―15 |
COVID-19 vaccination in adults with congenital heart disease: results of 1-year prospective study |
A S Roma, F Fusco, G Papaccioli, M Abbate, G Scognamiglio, A Merola, et al. (+8) M Palma, A Correra, N Borrelli, R Barracano, N Grimaldi, D Colonna, E Romeo, B Sarubbi |
173 |
[GO] |
2022―Okt―15 |
Risk of worsening heart failure and all-cause mortality following mRNA COVID-19 vaccination in patients with heart failure: a Danish nationwide real-world safety study |
C Sindet-Pedersen, F Michalik, J Emanuel Strange, D Moelager Christensen, T Alexander Gerds, C Andersson, et al. (+7) F Folke, T Biering-Soerensen, E Fosboel, C Torp-Pedersen, G Hilmar Gislason, L Koeber, M Schou |
174 |
[GO] |
2022―Okt―15 |
COVID-19 vaccination in the pediatric age and risk for myocarditis |
A Aimo, M Cantinotti, G Panichella, A Clerico |
175 |
[GO] |
2022―Okt―15 |
Acute effects of COVID-19 vaccination on inflammatory, macrovasular and microvascular biomarkers |
D Terentes-Printzios, V Gardikioti, E Solomou, E Emmanouil, I Gourgouli, P Xydis, et al. (+8) G Christopoulou, C Georgakopoulos, I Dima, A Miliou, G Lazaros, M Pirounaki, K Tsioufis, C Vlachopoulos |
176 |
[GO] |
2022―Okt―15 |
COVID-19 vaccine-induced myocarditis vs. immune checkpoint inhibitor-induced myocarditis - same but different? |
L Zornitzki, O Havakuk, Z Rozenbaum, D Viskin, A Arbel, S Banai, et al. (+2) Y Topilsky, M Laufer-Perl |
177 |
[GO] |
2022―Okt―15 |
Cardiac MRI findings in COVID-19 vaccine-related myocarditis: pooled analysis of 435 patients |
P Samimisedeh, E Jafari Afshar, N Shafiabadi, H Rastad |
178 |
[GO] |
2022―Okt―15 |
Constructing custom-made radiotranscriptomic signatures from CT angiograms: an application in COVID-19 vascular inflammation |
C P Kotanidis, C Xie, M Siddique, K Burnham, H Lockstone, R Kotronias, et al. (+8) H West, J Rodrigues, D Adlam, S Neubauer, K Channon, J Deanfield, L P Ho, C Antoniades |
179 |
[GO] |
2022―Okt―15 |
Factors of persistent limited exercise tolerance in patients after COVID-19 with normal left ventricular ejection fraction |
K Gryglewska, A Sakowicz, M Banach, M Maciejewski, A Bielecka-Dabrowa |
180 |
[GO] |
2022―Okt―15 |
Prognostic value of brain natriuretic peptide in COVID-19 with or without acute heart failure |
M Bergami, O Manfrini, E Cenko, M Dorobantu, I Demiri, O Fronea, et al. (+9) S Kedev, P Mjehovic, M Pasalic, L Poposka, M Stefanovic, M Vavlukis, D Milicic, M Zdravkovic, R Bugiardini |
181 |
[GO] |
2022―Okt―15 |
Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study |
K Matli, N Chamoun, A Fares, V Zibara, S Al-Osta, R Nasrallah, et al. (+3) P Salameh, J Mokhbat, G Ghanem |
182 |
[GO] |
2022―Okt―15 |
Aspirin therapy on prophylactic anticoagulation for hospitalized patients with COVID-19: a propensity score-matched cohort analysis of the HOPE-COVID-19 registry |
F Santoro, I Nunez Gil, E Vitale, J Perez-Villacastin, A Fernandez-Ortiz, N D Brunetti |
183 |
[GO] |
2022―Okt―15 |
No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers |
M Radvan, M Kamenik, L Koc, G Matejova, E Bartecku, J Horinkova, et al. (+2) R Stepanova, P Kala |
184 |
[GO] |
2022―Okt―15 |
Impact of coronavirus disease 2019 on adult patients with congenital heart disease |
I Cardoso, T Branco, A Constante, J Viegas, A Grazina, B Teixeira, et al. (+6) S Jacinto, A Castelo, T Rito, D Martins, R Ferreira, L Sousa |
185 |
[GO] |
2022―Okt―15 |
Effect of real-time remote-based cardiac rehabilitation on subjective satisfaction and objective performance during the coronavirus disease 2019 pandemic |
Y Fukuta, S Arizono, S Tanaka, T Kawaguchi, T Fuseya, N Tsugita, et al. (+3) J Magata, Y Tawara, T Segawa |
186 |
[GO] |
2022―Okt―15 |
Prediction of clinical outcomes in patients with coronavirus disease 2019 using high-sensitive troponin I and N-terminal pro-B-type natriuretic peptide |
M Sano, T Toyota, T Morimoto, T Okada, Y Sasaki, T Taniguchi, et al. (+8) K Kim, A Kobori, N Ehara, M Kinoshita, A Doi, K Tomii, Y Kihara, Y Furukawa |
187 |
[GO] |
2022―Okt―15 |
High sensitivity troponin I and newly/recently diagnosed coronavirus-19 disease patients presenting to the emergency department: values above and below the 99th percentile predict 28 day mortality |
R M Nowak, G Jacobsen, B Cook, S Linoj, M Moyer, D Lanfear |
188 |
[GO] |
2022―Okt―15 |
Cardiac dysrhythmias among coronavirus-19 recovered symptomatic patients |
D Shamia, G Tsaban, L Baham, Y Raviv, M Haim |
189 |
[GO] |
2022―Okt―15 |
The association of angiotensin-converting enzyme inhibitors and angiotensin 2 receptor blockers with renal protection in patients with SARS-CoV-2 |
A D Douen, S T Tan, M S Sukoo-Pertab, C B Bowser, O B Busari, W S Siu, et al. (+8) P R Panetti, S K Kedarisetti, W R Romney, R P Ramdass, W L Lee, G J Juang, A T Toreli, A S Soni |
190 |
[GO] |
2022―Okt―15 |
Atrial fibrillation incidence in SARS-CoV-2 infected patients: predictors and relationship with in-hospital mortality |
A Maloberti, C Giannattasio, P Rebora, G Occhino, N Ughi, S Fabbri, et al. (+9) I Cartella, M Algeri, S Scarpellini, C Rossetti, O M Epis, G Molon, P Bonfanti, M G Valsecchi, S Genovesi |
191 |
[GO] |
2022―Okt―15 |
Mid- and long-term atrio-ventricular mechanics in children after recovery from asymptomatic or mildly symptomatic SARS-CoV-2 infection |
J Sabatino, D Sirico, C Di Chiara, P Pogacnik, A Di Candia, F Bonfante, et al. (+9) D Dona, P Costenaro, J Fumanelli, E Reffo, B Castaldi, R Biffanti, A Cerutti, C Giaquinto, G Di Salvo |
192 |
[GO] |
2022―Okt―15 |
Cardiac impairment in Long Covid 1-year post SARS-CoV-2 infection |
A Roca-Fernandez, M Wamil, A Telford, V Carapella, A Borlotti, D Monteiro, et al. (+9) H Thomaides-Brears, A Dennis, R Banerjee, M D Robson, G Y H Lip, S Bull, M Heightman, N Ntusi, A Banerjee |
193 |
[GO] |
2022―Okt―15 |
Prevalence of abnormalities on cardiac MRI in unselected patients after recovery from acute SARS-CoV-2 infection and correlation with markers of immunity and coagulation: the SETANTA study |
R Colleran, R J Byrne, A Cradock, D O Ciardha, S McKeogh, H Wilson, et al. (+8) A Mansur, J Bisset, G Cantwell, M Hannan, M Fitzgibbon, J O Donnell, H Rai, R A Byrne |
194 |
[GO] |
2022―Okt―15 |
No deterioration in function or volumetric parameters in elite athletes after SARS-CoV-2 infections compared to non-infected athletes: results from the ELITE cohort |
J Van Hattum, S M Verwijs, J J N Daems, S M Boekholdt, M Groenink, R N Planken, et al. (+8) R D Van Luijk-Snoeks, A Van Der Randen, M H Moen, C A C M Wijne, A J Nederveen, Y M Pinto, A A M Wilde, H T Jorstad |
195 |
[GO] |
2022―Okt―15 |
SARS-CoV-2 is associated withabnormal biomarkers of oxidative stress,and endothelial function linked with cardiovascular dysfunction four months after the infection |
I Ikonomidis, A Kountouri, A Mitrakou, J Thymis, K Katogiannis, E Korakas, et al. (+9) C Varlamos, A Bamias, K Thomas, I Andreadou, M Tsoumani, D Kavatha, A Antoniadou, M A Dimopoulos, V Lambadiari |
196 |
[GO] |
2022―Okt―15 |
Association between cardiovascular comorbidities and hospital admission in SARS-CoV-2 patients |
A D Douen, S T Tan, W S Siu, R P Panetti, M S Sukoo-Pertab, C B Bowser, et al. (+5) O B Busari, W R Romney, P R Ramdass, G J Juang, A T Toreli |
197 |
[GO] |
2022―Okt―15 |
Apabetalone, a BET inhibitor, attenuates inflammation induced by viral RNA mimetic and reduces SARS-CoV-2 spike protein binding regardless of variants |
L Fu, D Gilham, S Stotz, C Sarsons, B Rakai, L Tsujikawa, et al. (+5) S Wasiak, J Johansson, M Sweeney, N Wong, E Kulikowski |
198 |
[GO] |
2022―Okt―15 |
SARS-CoV-2 vaccination and myocarditis in a highly vaccinated New Zealand population |
C Greer, M Daly, R Troughton, P D Adamson |
199 |
[GO] |
2022―Okt―15 |
Classic and genetic cardiovascular risk burden and case-fatality from SARS-CoV-2 virus infection. The CARGENCORS study |
A Camps-Vilaro, I R Degano, R Brugada, M Pinsach, R Elosua, R Ramos, et al. (+9) R Marti, I Subirana, X Nogues, J R Masclans, J Marin, R Guerri, H Tizon, B Vaquerizo, J Marrugat |
200 |
[GO] |
2022―Okt―15 |
Non-contrast cardiac magnetic resonance imaging after SARS-CoV2 infection or vaccination in asymptomatic adolescents: insights from the EnIGMA study |
R Parraga, C Real, I Garcia-Lunar, G Pizarro, J Sanchez-Gonzalez, R Diaz-Munoz, et al. (+9) E Gonzalez-Calvo, E Gutierrez-Ortiz, J Martinez-Gomez, M De Miguel, A De Cos-Gandoy, P Bodega, G Santos-Beneit, V Fuster, R Fernandez-Jimenez |
201 |
[GO] |
2022―Okt―15 |
Long COVID syndrome: a case-control study |
R A Xuereb, A Gatt, K Vella, R G Xuereb, C J Barbara, S Fava, C J Magri |
202 |
[GO] |
2022―Okt―14 |
Ventricular-arterial coupling impairment in patients recovered from COVID-19 |
S Lampsas, E Oikonomou, N Souvaliotis, A Anastasiou, O Katsarou, A Marathonitis, et al. (+9) A Lysandrou, I Tzima, S Sarantos, K Kalogeras, A Tsatsaragkou, V C Mystakidi, G Siasos, D Tousoulis, M Vavuranakis |
203 |
[GO] |
2022―Okt―14 |
The prognostic value of speckle tracking echocardiography in patients hospitalized with COVID-19 |
E Cwiek-Rebowska, J D Kasprzak, D Filipiak-Strzecka, E Szymczyk, K Wdowiak-Okrojek, P Wejner-Mik, et al. (+5) K Cygulska, K Kupczynska, B Michalski, D Miskowiec, P Lipiec |
204 |
[GO] |
2022―Okt―14 |
Subclinical myocardial dysfunction in patients with persistent dyspnea one year after COVID-19 |
M L Luchian, A Motoc, B Roosens, J Magne, H Chameleva, J Geers, et al. (+9) B Von Kemp, L Houard, K Van Den Bussche, S Boeckstaens, T De Potter, S Lochy, C Weytjens, S Droogmans, B Cosyns |
205 |
[GO] |
2022―Okt―14 |
Evaluation of myocardial work in patients recovered from the severe form of COVID-19 |
T L F Sousa, M J N N Alves, M D T Melo, A L P Albuquerque, J G Martins, L F B Botelho |
206 |
[GO] |
2022―Okt―14 |
Comparison of COVID-19 clinical course between LVAD recipients implanted before and during COVID-19 pandemic |
S Wisniowska-Smialek, P Rubis, I Gorkiewicz-Kot, G Wasilewski, M Kaleta, D Sobczyk, et al. (+3) E Dziewiecka, B Kapelak, K Wierzbicki |
207 |
[GO] |
2022―Okt―14 |
Long-term mayor adverse cardiovascular events after COVID-19 infection: a clinical score from a cohort of 2575 patients enrolled in the multicenter international HOPE 2 registry |
F Santoro, N Di Nunno, A Centola, R Cetera, V Le Rose, J Perez-Villacastin, et al. (+3) A Fernandez-Ortiz, I Nunez Gil, N D Brunetti |
208 |
[GO] |
2022―Okt―14 |
Abnormal echocardiographic findings after COVID-19 infection: a multicenter registry |
S Garcia-Zamora, J M Picco, A J Lepori, M I Galello, A K Saad, M Ayon, et al. (+9) N Monga-Aguilar, I Shehadeh, C F Manganiello, C Izaguirre, L N Fallabrino, S Ghibaudo, M Priotti, P M Merlo, N Gastaldello |
209 |
[GO] |
2022―Okt―14 |
The impact of COVID-19 on right ventricular function in chronic kidney disease patients |
L Tapoi, C Ureche, A Diaconu, V Vasiliu, L Siriteanu, T Andrian, et al. (+9) A Stefan, C Baluta, M Apetrii, G Dodi, I Nistor, M Onofriescu, R Sascau, C Statescu, A Covic |
210 |
[GO] |
2022―Okt―14 |
COVID-19 pandemic impact on heart failure epidemiology and outcomes in Poland. National database study |
M Zaleska-Kociecka, M Celinska-Spodar, K Podwojcic, M Maluchnik, D Walkiewicz, T Hryniewiecki, P Leszek |
211 |
[GO] |
2022―Okt―14 |
Impact of in-hospital medical management for COVID-19 pandemic on door-to-balloon time in patients with ST-elevation myocardial infarction |
A Takasaki, T Kurita, M Yanagisawa, A Ino, D Hiramatsu, A Ikmi, et al. (+9) H Ito, T Kato, S Fukuoka, T Sugimoto, T Nakata, J Masuda, M Tanabe, H Kakimoto, K Dohi |
212 |
[GO] |
2022―Okt―14 |
1-year mortality after myocardial injury in COVID-19 patients |
B F O Gomes, T M B Silva, G P Dutra, L S Peres, N D Camisao, I R R Menezes, et al. (+6) H C Goudar, A Butter, J L F Petriz, P R Carmo Junior, B B Pereira, G M M Oliveira |
213 |
[GO] |
2022―Okt―14 |
Use of artificial intelligence for point-of-care echocardiographic assessment of left ventricular ejection fraction among COVID-19 patients |
Z Dadon, N Levi, A Orlev, D Belman, A Butnaru, M Glikson, et al. (+2) S Gottlieb, E A Alpert |
214 |
[GO] |
2022―Okt―14 |
Monitoring of the lung fluid status in hospitalized COVID-19 patients for predicts outcome. Results of the IMPEDANCE-Corona Trial |
M Kleiner Shochat, J Mohsen, M Abu Rumi, E Hellou, M Abolil, C Singer, et al. (+4) M Kazatsker, O Kobo, A Roguin, S Meisel |
215 |
[GO] |
2022―Okt―14 |
COVID-19 vaccination decrease the risk of Intensive Care Unit hospitalisation in heart failure patients even in the time of Omicron variant: population based study |
J Parenica, J Jarkovsky, K Benesova, J Hlasensky, M Miklikova, P Kala, et al. (+3) T Ondrus, P Lokaj, L Dusek |
216 |
[GO] |
2022―Okt―14 |
The impact of long COVID on myocardial work performance |
M L Luchian, A Motoc, B Roosens, J Magne, K Van Den Bussche, H Chameleva, et al. (+4) T De Potter, L Houard, S Droogmans, B Cosyns |
217 |
[GO] |
2022―Aug―19 |
European Heart Journal paper on COVID-19 scoops top award for London-based researcher |
Judith Ozkan |
218 |
[GO] |
2022―Jun―17 |
Placing the risk of myopericarditis following COVID-19 vaccination into perspective |
Giovanna Liuzzo, Carlo Patrono |
219 |
[GO] |
2022―Apr―13 |
Increased risk of incident diabetes in patients with long COVID |
Francesco Paneni, Carlo Patrono |
220 |
[GO] |
2022―Mrz―14 |
European Society of Cardiology guidance for the management of cardiovascular disease during the pandemic and a focus on long COVID |
Filippo Crea |
221 |
[GO] |
2022―Feb―18 |
Not only lungs: COVID-19 hits platelets as well |
Dario Bongiovanni, Melissa Klug, Marco Valgimigli, Isabell Bernlochner |
222 |
[GO] |
2022―Feb―08 |
The association between neutrophil to lymphocyte ratio and echocardiographic parameters in hospitalised adults with COVID-19 - a retrospective analysis |
R Agarwal, G Priyonugroho, S Hertine, S H Wicaksono, P Almazini, D Zamroni, H S Muliawan |
223 |
[GO] |
2022―Feb―08 |
Demographic analysis and clinical outcomes of COVID-19 and myocardial infarction from a tertiary care centre in south India |
R Kongara, RAMESH Sankaran, T R Muralidharan, P Manokar, S Sadhanandham, S Nagendra Boopathy, et al. (+3) B Vinod Kumar, J V Balasubramaniyan, K Preetham |
224 |
[GO] |
2022―Feb―08 |
Palliative care for patients with cardiovascular disease and COVID-19 in a major referral hospital |
T Correa, A M S Simao, J V B Sobreira, F Yarshell, F B Anbar, R T De Carvalho |
225 |
[GO] |
2022―Feb―08 |
The association between transthoracic echocardiographic parameters and severity of COVID-19 in hospitalised adults - a retrospective analysis |
R Agarwal, G Priyonugroho, S Hertine, S H Wicaksono, P Almazini, D Zamroni, H S Muliawan |
226 |
[GO] |
2022―Feb―08 |
Symptomatology, prognosis and clinical findings of myocarditis as an adverse event of COVID-19 mRNA vaccine: a systematic review |
VIKASH Jaiswal, AKASH Jaiswal, NITYA Batra, D Mukherjee, R Ruchika, ANGELA Ishak, et al. (+4) U Maskey, GAZALA Hitawala, DAVID Song, YASAR Sattar |
227 |
[GO] |
2022―Feb―08 |
Impact of Covid-19 on cardiovascular clinics: are we ready for tele-medicine? |
M Mujtaba, FAISAL Khanzada, DANISH Qayyum, TAHIR Saghir, SHARF Buraro |
228 |
[GO] |
2022―Feb―08 |
Effectiveness of a home-based cardiovascular disease prevention program during the COVID-19 pandemic |
P Chockalingam, V Natarajan, T Sekar, A Rajaram, M M Yusuf, S Gunasekaran, et al. (+2) P G Nayar, V Chockalingam |
229 |
[GO] |
2022―Feb―08 |
Virtual medical research mentoring and collaboration: breaking the bounds of nationality during the COVID-19 pandemic |
J S K Chan, D H H Lau, E King, Y K L Shum, L Roever, T Liu, et al. (+9) K Ng, E C Dee, A Ciobanu, G Bazoukis, E Mahmoudi, D I Satti, K Jeevaratnam, A Baranchuk, G Tse |
230 |
[GO] |
2022―Feb―08 |
Impact of the anti-hypertensive diets virtual education towards knowledge, attitude, practice, and reduction of blood pressure during covid-19 pandemic |
A Andrianto, M Ardiana, A Yutha, B P D Khrisna, R A Nugraha, T S Putra, et al. (+5) A R Shahab, H Andrianto, I H Kikuko, A N Puspitasari, M R Hajjrin |
231 |
[GO] |
2022―Feb―08 |
Clinical manifestation and impact on management of acute coronary syndrome during covid-19 pandemic, lessons learnt from a tertiary care |
T Subburaja, K A Sambasivam, R Radhika, P Sankara Thiagarajan |
232 |
[GO] |
2022―Feb―08 |
Impact of the COVID-19 pandemic on cardiology services in the second year at a South Asian cardiac centre |
F A Cader, M M Haq, S R Khan |
233 |
[GO] |
2022―Feb―08 |
Early impact of COVID-19 pandemic on heart transplant volumes in Asia and Oceania: results from the Global Observatory on Donation and Transplantation (GODT) |
Y Manla, N Bader, G Bajwa, L Gobolos, F Alsindi, I Hamour, et al. (+2) H Ghalib, F Al Badarin |
234 |
[GO] |
2022―Feb―08 |
Correlation of cardiac biomarkers with computed tomography severity score in COVID-19 patients |
R Rivera, L Cuenza, T Razon-Cuenza |
235 |
[GO] |
2022―Feb―08 |
Anticoagulation practices and venous thromboembolism in COVID-19 patients in a Philippine tertiary hospital |
M Ramos |
236 |
[GO] |
2022―Feb―08 |
Thromboembolic complication among COVID-19 patients in the intensive care unit (ICU): a single-centre study from a Malaysian perspective |
H Zulkifly, F Mansor, I Abdul Halim Zaki, K S Eng, L C Kiok, T Ravi, et al. (+3) M Pathmanathan, S Abd Wahab, R Muda |
237 |
[GO] |
2022―Feb―08 |
Efficacy and safety of fondaparinux versus unfractionated heparin in patients hospitalised with severe COVID-19 pneumonia and coagulopathy: a randomised, open-label clinical trial |
L H Adrian, S A Hutomo, A D S Negari |
238 |
[GO] |
2022―Feb―08 |
Prevalence and predictors for high blood pressure during covid-19 vaccination in Thailand |
S Patamatamkul |
239 |
[GO] |
2022―Feb―08 |
Evaluation of outcome of Coronavirus disease 2019 patients receiving RAAS inhibitors (OCRAS study): a prospective observational study of Bangladeshi hypertensive patients |
A B D Majumder, M T Rahman, A K M Islam, M Ullah, M K Zaman, M A Reza, et al. (+9) M S Islam, R C Khan, M Z Rahman, M M Rahman, M A Awal, S Kabir, G K Paul, S Nasrin, S Zaman |
240 |
[GO] |
2022―Feb―08 |
Impact of SARS-CoV2 pandemic onto acute ST-elevation myocardial infarction care and patient outcomes in a large tertiary cardiac center |
D Yong, M A Sulong, M Sundarajoo, N Am Haris, M Y Low, K Kaniappan, A A Nuruddin |
241 |
[GO] |
2022―Feb―08 |
The role of STEMI integrated networking system based on tele-cardiology for reducing ischemic time and crossing wire time delayed during COVID 19 pandemic |
M Rizki Fadlan, S Anjarwani, M Saifur Rohman |
242 |
[GO] |
2022―Feb―08 |
A survey-based comparison of cardiovascular health risk behaviours in Indian men and women during the pandemic |
P Chockalingam, V Natarajan, T Sekar |
243 |
[GO] |
2021―Dez―31 |
Frequency and outcome of acute coronary syndrome during the Covid-19 pandemic |
R A Mousavi, C Wallmueller, P Stratil, G Pichler, F Piringer, G Delle Karth, A Schober |
244 |
[GO] |
2021―Dez―20 |
Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up |
|
245 |
[GO] |
2021―Okt―25 |
Impact of COVID-19 on angioplasty service and outcome of patients treated for critical limb ischaemia |
A Rodway, C Giltinan, A Dehghan-Nayeri, A Santos, M Stafford, M B Whyte, et al. (+7) C Allan, B Field, J Clark, F Pazos Casal, A Pankhania, T Loosemore, C Heiss |
246 |
[GO] |
2021―Okt―21 |
Stroke mechanisms associated with coronavirus disease (COVID-19) |
M Kruchinina, A A Gromov, V M Generalov, A V Rabko, V N Kruchinin |
247 |
[GO] |
2021―Okt―21 |
Echocardiogram in critically ill patients with COVID-19 |
B F O Gomes, T M B Silva, I R R Menezes, A S Azevedo, L S Peres, D F P Pereira, et al. (+9) G P Dutra, S A M Paula, B F S Mendes, J H P Nascimento, A L Cantisano, J L F Petriz, P R Carmo Junior, B B Pereira, G M M Oliveira |
248 |
[GO] |
2021―Okt―21 |
Impact of high cardiovascular risk on hospital mortality in patients admitted to intensive care by COVID-19 |
B F O Gomes, T M B Silva, G P Dutra, A S Azevedo, D F P Pereira, L S Peres, et al. (+5) J H P Nascimento, J L F Petriz, P R Carmo Junior, B B Pereira, G M M Oliveira |
249 |
[GO] |
2021―Okt―21 |
COVID-19 infection impact on cardiovascular and thrombotic events during acute phase and medium-term of the disease |
A Varela Lopez, L Diaz Argueso, C Broco Fernandez, C E Cacho Antonio, P J Antunez Muinos, O Otero Garcia, et al. (+9) V Jimenez Ramons, T Gonzalez Ferreiro, M Perez-Poza, M Bastos Fernandez, A Garcia Campos, A Varela Roman, J Lopez Pais, D Lopez Otero, J R Gonzalez Juanatey |
250 |
[GO] |
2021―Okt―21 |
Introduction of alternative rehabilitation method for the patients with cardiovascular diseases in conditions of the COVID-19 pandemic |
R V Nesterak, I P Vakaliuk, N V Yakymchyk, I Drapchak, N V Savchuk, V I Sovtus, et al. (+2) R S Grygoryshyn, S M Bardashevska |
251 |
[GO] |
2021―Okt―21 |
Cardiovascular evaluation with exercise testing using face mask during the COVID-19 pandemic |
H Ilarraza-Lomeli, J Rojano-Castillo, G Carazo-Vargas, P S Flores-Carrillo, C F Barrera-Ramirez, M D Rius-Suarez, H N Ortega-Aranda |
252 |
[GO] |
2021―Okt―21 |
The direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy |
D J Hammersley, R J Buchan, L Mach, R E Jones, B P Halliday, S K Prasad, et al. (+2) A Roberts, J S Ware |
253 |
[GO] |
2021―Okt―21 |
Impact of COVID-19 pandemic on surgical care of patients with acute aortic conditions |
X Yuan, U Rosendahl, G Asimakopoulos, C Quarto, B Rosser, J Gaer, et al. (+4) M Petrou, S Bhudia, T Bahrami, C Nienaber |
254 |
[GO] |
2021―Okt―21 |
Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up |
V De Marzo, P Clavario, R Lotti, C Barbara, A Porcile, G Guglielmi, et al. (+6) C Russo, A J Autala, R Griffo, G Parati, U Corra', I Porto |
255 |
[GO] |
2021―Okt―21 |
Clinical outcomes in COVID-19 patients with in-hospital cardiac arrest - an insight from multi-centre data |
M Mughal, I Kaur, S Waxman, H Gandhi, M Kakadia, Z Khakwani, et al. (+9) A Okoh, K Shah, A Obaid, V Sirpal, S Azad, A Jaffery, H Jagdey, I Tawfik, M Alam |
256 |
[GO] |
2021―Okt―21 |
Are there any long-term cardio-pulmonary limitations of hospitalized Covid-19 patients? |
R Badr Eslam, C Binder-Rodriguez, A Iscel, J Niebauer, R A Mousavi, C Kronberger, et al. (+2) C Wenisch, D Bonderman |
257 |
[GO] |
2021―Okt―21 |
Comparison of echocardiographic parameters of patients with COVID-19 pneumonia in hospital and three months after discharge |
E Yaroslavskaya, D Krinochkin, N Shirokov, E Gultyaeva, V Garanina, A Mamarina, et al. (+4) N Osokina, E Gorbatenko, N Musikhina, T Petelina |
258 |
[GO] |
2021―Okt―21 |
Critical COVID-19 rarely associated with left ventricular systolic impairment |
E Nakou, R Fisher, C Tountas, E Corcoran, A Dhariwal, A Marvaki, et al. (+9) A Hua, K O'Gallagher, A Nabeebaccus, P Pearson, T Fonseca, A Osborne, C Vega, M Monaghan, A Papachristidis |
259 |
[GO] |
2021―Okt―21 |
Frequent constriction-like echocardiographic findings in elite athletes following mild COVID-19: in the grasp of SARS-CoV-2? |
B K Lakatos, M Tokodi, A Fabian, Z Ladanyi, Z Eles, V Juhasz, et al. (+9) H Vago, N Sydo, E Csulak, A R Kiss, M Horvath, Z Gregor, O Kiss, B Merkely, A Kovacs |
260 |
[GO] |
2021―Okt―21 |
Impact of the first coronavirus-disease pandemic wave on cardiovascular admissions and sudden cardiac death rates in Greece |
E Pagourelias, V P Vassilikos, K Katsos, E Zaggelidou, N Raikos, S Tzikas, et al. (+9) C Tsavousoglou, A Kouparanis, A Anastasakis, G Kassimis, A Ziakas, G Sianos, H Karvounis, I Kanonidis, C Spiliopoulou |
261 |
[GO] |
2021―Okt―21 |
Myocardial injury in patients hospitalized for SARS-CoV19: a maker or a marker of prognosis? |
C Montalto, S Ghio, M Pagnesi, A Cappelletti, L Baldetti, E Baldi, et al. (+5) C Lombardi, L Lupi, M Metra, S Perlini, L Oltrona-Visconti |
262 |
[GO] |
2021―Okt―21 |
Discriminatory accuracy of the SOFA score for determining clinical decompensation in patients presenting with COVID-19 |
N Krepostman, M Collins, K Merchant, S De Sirkar, L Chan, S Allen, et al. (+5) J Newman, D Patel, J Fareed, S Berg, A Darki |
263 |
[GO] |
2021―Okt―21 |
Prehospital period in patients with COVID-19 and community acquired pneumonia: age characteristics, cardiovascular comorbidity and pharmacotherapy during epidemic wave (the data of hospital registry) |
M Lukiyanov, S Y Martsevich, A A Pulin, N P Kutishenko, E Y Andreenko, V A Dindikova, et al. (+9) A N Makoveeva, E Y Okshina, N A Dmitrieva, O V Lerman, V P Voronina, A V Zagrebelnyy, V G Klyashtorny, O E Karpov, O M Drapkina |
264 |
[GO] |
2021―Okt―21 |
Echocardiography and ECG monitoring not very beneficial in COVID-19 follow-up even in long haulers |
M Radvan, M Kamenik, L Koc, E Bartecku, L Sykorova, P Kala |
265 |
[GO] |
2021―Okt―21 |
Predictors of clinical decompensation in patients presenting with COVID-19 in an urban hospital health system |
N Krepostman, M Collins, K Merchant, S De Sirkar, L Chan, S Allen, et al. (+5) J Newman, D Patel, J Fareed, S Berg, A Darki |
266 |
[GO] |
2021―Okt―21 |
COVID-19 in pregnant women with heart diseases. Adverse maternal and fetal outcomes. Case series from InCor registry of Pregnancy and Heart Disease |
M R Kirschbaum, M S Devido, E Azeka, L M M F Demarchi, J S Santos, D V R Pinto, et al. (+4) L A Hajjar, F Tarasoutchi, M Park, W S Avila |
267 |
[GO] |
2021―Okt―21 |
Structure and predictors of repolarization disorders in patients with severe COVID-19 infection |
T D Danilevych, Y M Mostovoy, L V Rasputina |
268 |
[GO] |
2021―Okt―21 |
Closure of outpatient cardiac rehabilitation during the first COVID-19 lockdown in Austria in spring 2020 resulted in deteriorating physical exercise capacity: a mixed-methods study |
S T Kulnik, M Sareban, I Hoeppchen, S Droese, A Egger, J Gutenberg, et al. (+4) B Mayr, B Reich, D Wurhofer, J Niebauer |
269 |
[GO] |
2021―Okt―21 |
Levels of hypersensitive troponin T in the emergency department as a predictive factor of mortality for hospitalized COVID-19 patients |
Y P Pionnier, P D Denoel, A M Manara, K Brousmiche |
270 |
[GO] |
2021―Okt―21 |
Assessment of vascular endothelial function in COVID-19 patients |
H Mejia-Renteria, A Travieso, A Sagir, E Martinez-Gomez, A Carrascosa-Granada, I Nunez-Gil, et al. (+3) V Estrada, A Lerman, J Escaned |
271 |
[GO] |
2021―Okt―21 |
Previous psychiatric disorders and antipsychotic drugs in COVID-19 patients: early findings on possible worse outcome |
M Scarpone, M Bergami, E Cenko, R Bugiardini, E Poluzzi, O Manfrini |
272 |
[GO] |
2021―Okt―21 |
Psychological profile of COVID-19 pneumonia survivors three month after hospitalization |
E Yaroslavskaya, O Guskova, B Prilenskii, T Petelina |
273 |
[GO] |
2021―Okt―21 |
Laboratory indicators of inflammation and systolic function of the left and right ventricles in patients with cardiovascular disease who have undergone COVID-19-associated pneumonia |
N Musikhina, T Petelina, E Yaroslavskaya, D Krinochkin, N Shirokov, N Osokina, E Gorbatenko |
274 |
[GO] |
2021―Okt―21 |
Obesity strongly predicts COVID-19-related major clinical adverse events in Coptic Clergy |
M Y Henein, I Bytyci, R Nicoll, S Rafik, S Ayad, F Vanchari |
275 |
[GO] |
2021―Okt―21 |
Interventional cardiology in times of COVID-19: impact on a terciary centre |
A Azul Freitas, C Ferreira, S Martinho, V Goncalves, J Almeida, J Rosa, et al. (+3) G Campos, E Jorge, L Goncalves |
276 |
[GO] |
2021―Okt―21 |
Effect of body mass index on cardiac injury/cardiovascular outcomes in coronavirus disease 2019: a systematic review and meta-analysis |
M Ashraf, V Zlochiver, M S Rawala, M Dahar, J Robinson, M F Jan |
277 |
[GO] |
2021―Okt―21 |
Cardiac troponin as major mortality risk factor in SARS-CoV-2 infection |
A Gonzalez Leal, S Antonana Ugalde, A Arteagoitia Bolumburu, J M Monteagudo Ruiz, R R Martinez Moya, R Ortega Perez, et al. (+5) S Rivas Garcia, M A Sanroman Guerrero, A Lorente Ros, L M Rincon Diaz, J L Zamorano Gomez |
278 |
[GO] |
2021―Okt―21 |
SARS-CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players |
S Fikenzer, A Kogel, P Hepp, D Lavall, S T Stoebe, U Rudolph, et al. (+2) U Laufs, A Hagendorff |
279 |
[GO] |
2021―Okt―21 |
The impact of anxiety level on medical decisions of non-COVID patients during the pandemic outbreak |
O Koren, S Abu Rajab, M Barbour, M Shachar, A Shahar, K Zubidat, et al. (+5) W Slim, D Igbariya, E Rozner, Y Turgeman, E Mader |
280 |
[GO] |
2021―Okt―21 |
Patterns of cardiac involvement in patients with long COVID syndrome using cardiovascular magnetic resonance |
V Puntmann, S Martin, B Vanchin, N Holm, E Giokoglu, J Hoffmann, et al. (+9) A Karyou, C Arendt, Y Khodamoradi, M Vehreschild, A Braner, G Rohde, A Zeiher, T Vogl, E Nagel |
281 |
[GO] |
2021―Okt―20 |
Cardiac arrhythmias 3 months after hospitalization for COVID-19 |
C B Ingul, J Grimsmo, A Mecinaj, D Trebinjac, M Berger Nossen, S Andrup, et al. (+4) K Stavem, T Josefsen, T Omland, T Jensen |
282 |
[GO] |
2021―Okt―20 |
Impact of the COVID-19 pandemic on emergent pacemaker implantation during lockdown and its aftermath |
D De Almeida Fernandes, R Cadete, J Guimaraes, E Monteiro, G Costa, N Antonio, L Goncalves |
283 |
[GO] |
2021―Okt―20 |
Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease |
H Barman, A Atici, H O Arabaci, I Sahin, B Gungor, S M Dogan |
284 |
[GO] |
2021―Okt―20 |
Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination |
Filippo Crea |
285 |
[GO] |
2021―Okt―20 |
Impact of COVID-19 in adult patients with congenital heart disease |
I Cardoso, T B Branco, A Constante, J Martins, L Sousa, J Viegas, et al. (+2) T Rito, R C Ferreira |
286 |
[GO] |
2021―Okt―20 |
The impact of the COVID-19 pandemic on the management and outcomes of STEMI patients in Switzerland |
S Fournier, T Mahendiran, D Radovanovic, G Pedrazzini, F Eberli, M Roffi, et al. (+2) R Kobza, H Rickli |
287 |
[GO] |
2021―Okt―20 |
Comparison of D-dimer level measured on the third day of hospitalization with D-dimer level in predicting in-hospital mortality in COVID-19 patients |
M Selcuk, T Cinar, N Gunay, M Keskin, V Cicek, S Kilic, et al. (+2) S Asal, A L Orhan |
288 |
[GO] |
2021―Okt―20 |
Modified CHA2DS2-VASc can predict mortality in COVID-19 patients admitted to the emergency department |
B V Silva, C Jorge, C Mendonca, M L Urbano, T Rodrigues, P Silverio Antonio, et al. (+9) J Brito, P Alves Da Silva, B Garcia, C Martins, J Rigueira, I Ricardo Aguiar, M Nobre Menezes, R Placido, F J Pinto |
289 |
[GO] |
2021―Okt―20 |
Cardiac biomarkers as prognosticators among SARS-CoV-19 patients in a tertiary hospital in Philippines |
R Ong, C Chacon, S Javier |
290 |
[GO] |
2021―Okt―20 |
Impact of type 2 diabetes mellitus on clinical outcomes in patients with COVID-19 and cardiovascular disease |
K G Lobanova, T Y U Demidova, V M Plakhotnyaya |
291 |
[GO] |
2021―Okt―20 |
Outcomes of COVID-19 infection in heart transplant recipients |
D Miklin, A Mantha, A Wolfson, A Vaidya, E Depasquale |
292 |
[GO] |
2021―Okt―20 |
Impact of COVID-19 lockdown on the procedural and intra-hospital outcome of STEMI patients |
L Gaede, H Rittger, H Gerrens, A Achajew, N Schacher, P Ferstl, et al. (+4) M Troebs, M Arnold, M Marwan, S Achenbach |
293 |
[GO] |
2021―Okt―20 |
Impact of COVID-19 on heart failure hospitalizations: one year after |
R Gonzalez-Manzanares, G Heredia Campos, C Fernandez-Aviles Irache, A Resua Collazo, C Pericet-Rodriguez, I Gallo-Fernandez, et al. (+9) A Fernandez-Ruiz, L Carnero Montoro, M.J Oneto-Fernandez, A Luque-Moreno, N Paredes-Hurtado, D Pastor-Wulf, J Lopez-Baizan, J.C Castillo-Dominguez, M Anguita |
294 |
[GO] |
2021―Okt―20 |
Prehospital ECG in patients with acute myocardial infarction during the COVID-19 pandemic |
M Avvedimento, A Leone, A Spinelli, A Franzone, G Esposito, R Piccolo |
295 |
[GO] |
2021―Okt―20 |
Impact of telehealth in the outpatient management of atrial fibrillation during the COVID-19 pandemic |
I Shatla, Y Sammour, K Kennedy, A P Wimmer |
296 |
[GO] |
2021―Okt―20 |
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in Israel |
E Asher, A Fardman, D Zahger, K Orvin, M Mohsen, O Tsafrir, et al. (+9) R Rubinshtein, J Jamal, R Efraim, N Kofman, M Halabi, Y Shacham, L Henri Fortis, R Beigel, S Matetzky |
297 |
[GO] |
2021―Okt―20 |
Indirect effects of COVID-19 Pandemic in ST-segment elevation myocardial infarction: insights from a multicentric national survey |
H Pereira, R Cale, P Farto-Abreu, E Pereira, S S L On Behalf Of Stent Save A Life Initiative |
298 |
[GO] |
2021―Okt―20 |
Effects of remote monitoring of patients with heart failure based on smartphone application in the context of the COVID-19 pandemic in the Kyrgyz Republic |
A R Rustambekova, M R Djusupbekova, A A Moldobaeva, A I Moldomamatova, A M Noruzbaeva |
299 |
[GO] |
2021―Okt―20 |
Impact of the Covid-19 pandemic on the device therapy for patients with the heart failure |
R Hall, R Chattopadhyay, P.J Pugh |
300 |
[GO] |
2021―Okt―20 |
In-hospital predictors of 60-day readmission in COVID-19 patients |
M Ruge, A Gill, J M D Gomez, J Du Fay De Lavallaz, J A Simmons, K A Williams, et al. (+4) A S Volgman, K Marinescu, A Rao, T Suboc |
301 |
[GO] |
2021―Okt―20 |
The impact of daily troponin-I and D-dimer serum levels on mortality of moderate-to-severe COVID-19 pneumonia patients |
B Stavileci, E Ozdemir |
302 |
[GO] |
2021―Okt―20 |
Prognostic significance of N-Terminal Pro-BNP in patients with COVID-19 pneumonia without previous history of heart failure |
M Selcuk, M Keskin, T Cinar, N Gunay, S Dogan, V Cicek, et al. (+5) S Kilic, S Asal, S Yavuz, N Keser, A.L Orhan |
303 |
[GO] |
2021―Okt―20 |
Three-month cardiac outcomes of survivors of COVID-19 presenting to a district general hospital in West Hertfordshire, UK |
P K Pyae, A Navarra, R Webb, A Newland-Smith, R Vancheeswaran, J Sehmi, A Barlow |
304 |
[GO] |
2021―Okt―20 |
Biochemical and cardiovascular predictors of PIMS risk in children after COVID-19 recovery =- the results of the LATE COVID Kids study |
I Jatczak-Pawlik, J Lewek, E Czkwianianc, K Zeman, P Jankowski, M Banach |
305 |
[GO] |
2021―Okt―20 |
Hypertension as a prognostic factor in the prediction of mortality in patients with COVID-19: a systematic review and meta-analysis |
C D P Pagdanganan, J Juangco |
306 |
[GO] |
2021―Okt―20 |
Role of telemedicine network provided by pharmacies to detect acute myocardial infarction in patients with chest pain during coronavirus pandemia |
F Fioretti, M Piazzani, D S Cani, A Madureri, G F Gensini, F Gabbrielli, et al. (+3) G Bollani, F Glisenti, S Nodari |
307 |
[GO] |
2021―Okt―20 |
Cardiovascular predictors associated with poor short-term prognosis in patients diagnosed with SARS-CoV-2 in Spain |
L Esteban-Lucia, A Devesa-Arbiol, M A Zambrano Chacon, A M Venegas Rodriguez, M Gonzalez-Rodriguez, L Maure-Blesa, et al. (+9) P Avila-Barahona, A M Pello-Lazaro, O Gonzalez-Lorenzo, R Fernandez-Roblas, F Villar-Alvarez, B Ibanez, J Tunon, A Acena Navarro, J A Franco Pelaez |
308 |
[GO] |
2021―Okt―20 |
The surgical management of heart failure: heart transplantation in the era of SARS-CoV-2 pandemic |
J Malyszek, M Jasinska, M Zembala, K Ratman, B Krol, K Tkocz, et al. (+4) K Pelar, P Sybila, M Pajor, Z Nawrat |
309 |
[GO] |
2021―Okt―20 |
Sars-CoV2- infection as a trigger of humoral response against apolipoprotein A-1 |
S Pagano, S Yerly, N Suh, C Le Terrier, L Farrera-Soler, G Piumatti, et al. (+9) C S Eberhardt, C A Siegrist, I Eckerle, S Stringhini, I Guessous, L Kaiser, J Pugin, N Winssinger, N Vuilleumier |
310 |
[GO] |
2021―Okt―20 |
Post-COVID myocarditis diagnosed by endomyocardial biopsy and/or magnetic resonance imaging 2-9 months after acute COVID-19 |
O Blagova, D H Ainetdinova, Y U A Lutokhina, V M Novosadov, R S Rud', A Y U Zaitsev, et al. (+3) A D Kukleva, S A Alexandrova, E A Kogan |
311 |
[GO] |
2021―Okt―20 |
Atrial fibrillation is associated with poor clinical trajectory of COVID-19 |
S.J Stjepan Jurisic, M.K Komminoth, B.W Wiggli, D.A.B Bertschi, P.K Koepfli, I.V Vranjic, et al. (+9) A.F Friedl, J.C Contartese, F.F Fontana, H.S Schmid, J.R Rutishauser, C.G Gebhard, A.T Todorov, J.B Beer, D Patriki |
312 |
[GO] |
2021―Okt―20 |
Cardiovascular outcomes in hospitalized patients with COVID-19 and history of cancer: a CORONA-VTE analysis |
C D Khairani, B M Barns, S M Rizzo, M B Pfeferman, J E Snyder, S Z Goldhaber, G Piazza |
313 |
[GO] |
2021―Okt―20 |
Increased incidence of Persistent Pulmonary Hypertension of the Newborn following third trimester maternal COVID-19 infection |
A Ishqeir, A Nir, I Aptowitzer, M Godfrey |
314 |
[GO] |
2021―Okt―20 |
Blood pressure changes during the the COVID-19 pandemic and associated lockdown period |
N Girerd, C Meune, K Duarte, V Vercamer, M Lopez-Sublet, J J Mourad |
315 |
[GO] |
2021―Okt―20 |
Combined cardiac risk factors predict COVID-19 related mortality and the need for mechanical ventilation in Coptic Clergy |
M Y Henein, I Bytyci, R Nicoll, R Sheneuda, S Ayad, M Cameli, F Vancheri |
316 |
[GO] |
2021―Okt―20 |
Meta-Analysis of COVID-19 treatments on patients with a previous diagnosis of cardiovascular disease |
S Ben-Aicha, J Buchanan, M Moscarelli, P Punjabi, C Emanueli |
317 |
[GO] |
2021―Okt―20 |
Myocardial ischaemia of non-obstructive origin as a cause of new onset anginal chest pain in the long COVID syndrome |
C Espejo, H Mejia-Renteria, A Travieso, N Gonzalo, S Fernandez, M L Capote, et al. (+8) O Vedia, L Wang, I Nunez-Gil, J M Grande Ingelmo, I Fernandez Rozas, C Olmos, D Vivas, J Escaned |
318 |
[GO] |
2021―Okt―19 |
Atrial fibrillation as a risk factor of severe course of COVID-19 |
A Mielczarek, J D Kasprzak, M Plewka |
319 |
[GO] |
2021―Okt―19 |
The correlation of anti-heart antibodies levels with clinical manifestations and outcomes in patients with COVID-19 |
O Blagova, N V Varionchik, V A Zaidenov, P O Savina, N D Sarkisova |
320 |
[GO] |
2021―Okt―19 |
Erythrocytes induce vascular dysfunction in COVID-19 |
A Mahdi, A Collado, J Tengbom, T Jiao, T Wodaje, J Yang, et al. (+3) J O Lundberg, Z Zhou, J Pernow |
321 |
[GO] |
2021―Okt―19 |
Clinical effects of the enhanced external counterpulsation therapy in patients with ischemic chronic heart failure exacerbation COVID-19 |
I Shashenkov, S.A Gabrusenko, S.L Babak, A.G Maliavin |
322 |
[GO] |
2021―Okt―19 |
Prognostic value of atrial fibrillation in COVID-19 admitted patients |
A Santos Sanchez, P E Gonzalez-Recio, E Sanchez-Corral, J J Jimenez-Nacher |
323 |
[GO] |
2021―Okt―19 |
Frontal QRS/T angle can predict mortality in COVID-19 patients |
R Gunduz, B S Yildiz |
324 |
[GO] |
2021―Okt―19 |
Changes in health perception of COVID-19 among patients with aortic diseases: a longitudinal study between the first and second wave of the COVID-19 pandemic |
A Parys, S Klinge, A Doenmez, C Rammos, T Rassaf, A Janosi, J Lortz |
325 |
[GO] |
2021―Okt―19 |
Prospective analysis of inflammatory response markers, endothelial dysfunction and hemostasis parameters in COVID-19 associated pneumonia patients with and without type 2 diabetes mellitus |
T Petelina, N Musikhina, K Avdeeva, S Leonovich, L Gapon, E Gorbatenko, et al. (+6) Y Sharoyan, E Zueva, E Yaroslavskaya, E Gultyaeva, E Kalyuzhnaya, A Shcherbinina |
326 |
[GO] |
2021―Okt―19 |
Acute myocardial infarction in the Covid-19 era: incidence, clinical characteristics and in-hospital outcomes - a multicenter registry |
A Fardman, D Zahger, K Orvin, N Kofman, J Mohsen, O Tsafrir, et al. (+9) E Asher, R Rubinshtein, J Jamal, R Efraim, M Halabi, Y Shacham, L H Fortis, R Beigel, S Matetzky |
327 |
[GO] |
2021―Okt―19 |
Cardiac implantable electronic devices: a marker for poor outcome in patients with COVID-19 infection |
B Wizman, M Haim, N Yasoor, I Peles, V Novack, Y Konstantino |
328 |
[GO] |
2021―Okt―19 |
Arrhythmia patterns in patients with COVID-19 infection during and post hospitalization detected via a patch-based mobile cardiac telemetry system |
O Reynbakh, E D Braunstein, M Hsu, J Ellis, L Crosson, J Lenane, et al. (+3) A Krumerman, L Di Biase, K J Ferrick |
329 |
[GO] |
2021―Okt―19 |
Higher incidence of stroke in severe COVID-19 is not associated with a higher burden of arrhythmias: comparison to other types of severe pneumonia |
P Jirak, Z Shomanova, R Larbig, D Dankl, N Frank, C Seelmaier, et al. (+9) D Butkiene, M Lichtenauer, B Strohmer, J Sackarnd, U Hoppe, J Sindermann, H Reinecke, R Pistulli, L Motloch |
330 |
[GO] |
2021―Okt―19 |
The bimodal rise and fall acute coronary syndromes curves paralleling COVID-19 outbreaks |
D Trabattoni, G Teruzzi, P M Ravagnani, G Santagostino Baldi, P Montorsi, G Calligaris, et al. (+2) S Galli, A L Bartorelli |
331 |
[GO] |
2021―Okt―19 |
Stent-Save a Life international survey on the practice of primary coronary angioplasty during the COVID-19 pandemic |
H Pereira, S S L On Behalf Of Stent Save A Life Initative |
332 |
[GO] |
2021―Okt―19 |
STEMI patients in the first and second wave of COVID-19 pandemic in Slovenia |
A Sinkovic, M Krasevec, J Golub, D Suran, M Marinsek, A Markota |
333 |
[GO] |
2021―Okt―19 |
Feasibility of remote support for electrophysiological ablation procedures during CoVid-19 pandemics |
A Muessigbrodt, F Demoniere, S Finoly, M Mommarche, J Inamo |
334 |
[GO] |
2021―Okt―19 |
Dynamics of myocardial global longitudinal strain in patients with COVID-19 without significant baseline cardiovascular pathology |
S Iakovlev, O Dukhin, E Ryzhkova, E Andreeva, A Kalinskaya |
335 |
[GO] |
2021―Okt―19 |
Clinical and morphological characteristics of COVID-19-associated myocarditis |
E A Kogan, A D Kukleva, O V Blagova, Y U S Berezovskij |
336 |
[GO] |
2021―Okt―19 |
Cardiac arrest in patients hospitalized for COVID-19: a tertiary medical center retrospective cohort study |
S Luo, J M Du-Fay-De-Lavallaz, J M D Gomez, S Fugar, L Golemi, C J Chiang, et al. (+5) T Suboc, J A Simmons, K A Williams, A S Volgman, J Wasserlauf |
337 |
[GO] |
2021―Okt―19 |
Expressing a truncated SARS-COV-2 spike protein in mouse heart induces cardiac hypertrophy |
S Negron, C Kessinger, Z Lin |
338 |
[GO] |
2021―Okt―19 |
Novel SARS-CoV-2 variants induce higher toxicity in cardiovascular cells |
J U G Wagner, D Bojkova, M Shumliakivska, G S Aslan, J D Kandler, A Hansen, et al. (+5) J Krishnan, A M Zeiher, S Ciesek, J Cinatl, S Dimmeler |
339 |
[GO] |
2021―Okt―18 |
Cardiac function is normal in most patients recovered from COVID-19 |
J Tangen, P Aukrust, A Barrat-Due, M Troseid, I Christoffer Olsen, K Nezvalova-Henriksen, et al. (+9) T Kaasine, A M Dyrhol-Riise, A Rygh Holten, A K Finbraten, T A Josefsen, K C Lee, K H Haugaa, H Skulstad, T Edvardsen |
340 |
[GO] |
2021―Okt―18 |
Mid-term endothelial dysfunction post COVID-19 |
S Lampsas, E Oikonomou, G Siasos, N Souvaliotis, A Goliopoulou, C V Mistakidi, et al. (+6) P Theofilis, G Vogiatzi, K Kalogeras, E Katsianos, D Tousoulis, M Vavuranakis |
341 |
[GO] |
2021―Okt―18 |
The role of cardiovascular calcifications in COVID-19 |
M Toselli, A C Cereda, F G Giannini, A S Scoccia, G G Gallone, A P Palmisano, et al. (+2) D V Vignale, A E Esposito |
342 |
[GO] |
2021―Okt―18 |
Clinical and echocardiographic risk score predicts need for hospitalization among patients with COVID-19 |
J Kothari, K Shah, T Daly, P Saraiya, I Taha, M Le, et al. (+2) H Goel, J Shirani |
343 |
[GO] |
2021―Okt―18 |
Long-term post-discharge coagulation abnormalities in patients with moderate to severe COVID-19 |
G Artemyeva, A Kalinskaya, O Dukhin, A Lebedeva, A Rozin, A Shpektor, E Vasilieva |
344 |
[GO] |
2021―Okt―18 |
The role of premorbid transthoracic echocardiogram in identifying adverse clinical outcomes in patients admitted with COVID-19 |
C Lee, N Patel, L Panepinto, M Byers, M Ambrosino, S Adusumalli, et al. (+3) S Denduluri, J Cohen, M Scherrer-Crosbie |
345 |
[GO] |
2021―Okt―18 |
Cardiac involvement in patients recovered from coronavirus disease-2019 (COVID-19): a systematic review |
N Shafiabadi, H Rastad, M Mozafarybazargany, H Talakoob, H Karim |
346 |
[GO] |
2021―Okt―18 |
Longitudinal trajectory of cardiac magnetic resonance and cardiopulmonary exercise testing findings in moderate to severe COVID-19 and association with symptoms |
M P Cassar, A J Lewandowski, M Mahmod, C Xie, E M Tunnicliffe, N Petousi, et al. (+4) N P Talbot, D Holdsworth, S Neubauer, B Raman |
347 |
[GO] |
2021―Okt―18 |
Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin |
C K Kaufmann, A A Ahmed, M K Kassem, M F Freynhofer, B J Jaeger, G A Aicher, et al. (+8) S E Equiluz-Bruck, A S Spiel, F V Vafai-Tabrizi, M G Gschwantler, P F Fasching, J W Wojta, E G Giannitsis, K H Huber |
348 |
[GO] |
2021―Okt―18 |
Impact of COVID-19 disease on platelet reactivity and association with inflammatory parameters |
M Ascencio, M Munoz-Esquerre, Y Pascual, M Iglesias, J Sabater, O Murillo, et al. (+5) S G Sosa, J A Gomez-Hospital, S Santos, J Comin-Colet, J L Ferreiro |
349 |
[GO] |
2021―Okt―18 |
Echocardiographic markers of mortality at 60 days in patients with COVID-19 in the intensive care unit |
J Sprockel, J M Rincon, M Rondon, M Bejarano, N Castellanos, Z Santofimio, et al. (+4) H M Cardenas, D Hernandez, J E Parra, J J Diaztagle |
350 |
[GO] |
2021―Okt―18 |
Is endothelial dysfunction a driving force of COVID-19 induced coagulopathy? |
O Dukhin, A Kalinskaya, I Molodtsov, A Maltseva, D Sokorev, A Elizarova, et al. (+8) K Glebova, D Stonogina, S Shakhidzhanov, I Spiridonov, F Ataullakhanov, L Margolis, A Shpektor, E Vasilieva |
351 |
[GO] |
2021―Okt―18 |
Consequences on the right ventricular to pulmonary circulation coupling of COVID-19 infection |
A M Vella, F Bursi, G Santangelo, A Barbieri, F Toriello, F Valli, et al. (+3) D Sansalone, S Carugo, M Guazzi |
352 |
[GO] |
2021―Okt―18 |
Clinical impact on treatment and prognosis of advanced cardiac imaging with echocardiography in the acute setting of a COVID-19 infection |
M Gonzalez Del Hoyo, L Servato, R Fernandez-Galera, E Rodenas, M Garcia, G Casas, et al. (+9) P Jordan, L Herrador, M Bach, F Valente, L Gutierrez, J Baneras, A Evangelista, I Ferreira, J Rodriguez-Palomares |
353 |
[GO] |
2021―Okt―18 |
Stress myocardial blood flow reduced after severe COVID-19, not related to symptoms |
P Doeblin, C Goetze, S Al-Tabatabaee, A Berger, F Steinbeis, M Witzenrath, et al. (+7) A Faragli, C Stehning, A Chiribiri, C M Scannell, E Alskaf, B Pieske, S Kelle |
354 |
[GO] |
2021―Okt―18 |
Prognostic value of coronary artery calcium score in hospitalized COVID-19 patients |
A Motoc, M L Luchian, S Lochy, D Belsack, J Magne, B Roosens, et al. (+9) J De Mey, S Boeckstaens, K Van Den Bussche, B Von Kemp, X Galloo, C Francois, C Weytjens, S Droogmans, B Cosyns |
355 |
[GO] |
2021―Okt―18 |
Pocket-size ultrasound devices may improve the prompt assessment of Covid-19 patients |
D Filipiak, J D Kasprzak, P Lipiec |
356 |
[GO] |
2021―Okt―18 |
Preponderance of right ventricular dysfunction in COVID-19 patients with inflammatory heart disease |
S T Thodeti, D S L Lattanzio, T M K Kuraan, M U K Khalid, D D Drenic, R S R Raghupathy, et al. (+2) S V V Vallabhaneni, J R M Mikolich |
357 |
[GO] |
2021―Okt―18 |
Initial COVID-19 symptoms are not predictive of post-COVID recovery inflammatory heart disease detected by cardiac MRI |
S T Thodeti, D S L Lattanzio, D D Drenic, T M K Kuraan, M U K Khalid, S V V Vallabhaneni, J R M Mikolich |
358 |
[GO] |
2021―Okt―18 |
Association between cardiac pathology and outcomes of patients with COVID-19 using a hand-held ultrasound |
Z Dadon, N Levi, A Orlev, D Belman, E A Alpert, Y Steinmetz, et al. (+4) A Wolak, M Glikson, S Gottlieb, A Butnaru |
359 |
[GO] |
2021―Okt―18 |
Early microvascular modifications in patients previously hospitalized for COVID-19: comparison with healthy individuals |
P Malerba, C Agabiti Rosei, M Nardin, A Gaggero, G Chiarini, C Rossini, et al. (+6) F Fama', V Brami, M A Coschignano, M L Muiesan, D Rizzoni, C De Ciuceis |
360 |
[GO] |
2021―Okt―18 |
Cytokine storm induced coagulopathy in septic shock and critical Covid-19: head-to-head comparison |
M D M Dechamps, J De Poortere, P F Laterre, M Octave, A Ginion, V Robaux, et al. (+9) J Bodart, D Gruson, M Van Dievoet, J Douxfils, M Derive, A Campion, M Martin, S Horman, C Beauloye |
361 |
[GO] |
2021―Okt―18 |
Can echocardiographic parameters predict mortality in COVID-19? |
A Babu, N Eden, Z Meng, D Lamb, R Bhatia, V Voon |
362 |
[GO] |
2021―Okt―18 |
Echocardiographic parameters as predictors of three-months mortality in patients with 2019 Coronavirus infection |
T Miranda Aquino, J M Pereira-Forcado, B Ordonez-Salazar, G Dominguez-Trejo, A Rangel-Guerra, J Martinez-Castillo, et al. (+6) R J Vazquez-Orozco, A P Guevara-Canseco, S E Perez-Topete, R Aceves-Millan, L Amezcua-Gomez, C Ixcamparij-Rosales |
363 |
[GO] |
2021―Okt―18 |
Clinical characteristics and in-hospital outcomes of patients coinfected with Chagas disease and SARS-CoV-2 |
M Marcolino, I Molina, M C Pires, L E F Ramos, R T Silva, M H Guimaraes Junior, et al. (+9) R L R Carvalho, A L R M Barros, A L Ribeiro, H Duani, F Anschau, F A Botoni, N R Oliveira, C A Polanczyk, M C P Nunes |
364 |
[GO] |
2021―Okt―18 |
The SARS-CoV-2 Spike protein alters human cardiac pericyte function and interaction with endothelial cells through a non-infective mechanism involving activation of CD147 receptor signalling |
E Avolio, M Carrabba, M Kavanagh Williamson, R Milligan, K Gupta, M Gamez, et al. (+6) R Foster, I Berger, M Caputo, A Davidson, D Hill, P Madeddu |
365 |
[GO] |
2021―Sep―23 |
Transforming community cardiology practice to virtual visits: innovation at Cleveland Clinic during the COVID-19 pandemic |
Gautam V Shah, Ankur Kalra, Umesh N Khot |
366 |
[GO] |
2021―Aug―11 |
The 2020 Olympic/Paralympic Games and Covid-19 in Japan |
Hiroaki Shimokawa |
367 |
[GO] |
2021―Aug―06 |
Can the US COVID-19 Response Advance Equity in Cardiovascular Health? |
Erica S Spatz, Adam L Beckman, Oyere K Onuma, Elias Mossialos |
368 |
[GO] |
2021―Jun―28 |
Maintaining high standards of clinical research during the Covid-19 pandemic: insights from an excellence clinical research centre |
Mattia Lunardi, Darren Mylotte, William Wijns, Yoshinobu Onuma, Osama Soliman, Patrick W Serruys, Faisal Sharif |
369 |
[GO] |
2021―Mai―29 |
COVID-19 and the heart: insights from the National Societies of Cardiology Journals |
Jean-Jacques Monsuez |
370 |
[GO] |
2021―Mai―13 |
Cardio Egypt 2021: one of the first physical meetings in the era of Covid-19 |
Magdy Abdelhamid, Mohamed Osama, Khaled Shokry |
371 |
[GO] |
2021―Mai―08 |
The ongoing impact of COVID-19 on cardiovascular care |
Mark Nicholls |
372 |
[GO] |
2021―Apr―16 |
Old and new enemies: psychological stress, occupational stress, COVID-19, and a glimpse of the future |
Filippo Crea |
373 |
[GO] |
2021―Apr―07 |
Erratum to: Conducting Clinical Trials in Heart Failure During (and After) the COVID-19 Pandemic: An Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) |
|
374 |
[GO] |
2021―Apr―06 |
Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19 |
Ulf Landmesser, Irina Lehmann, Roland Eils |
375 |
[GO] |
2021―Mrz―26 |
COVID-19 and Emissions: An Opportunity for Sustainable Global Health |
Sanjay Rajagopalan, Robert B Jackson, Jagat Narula |
376 |
[GO] |
2021―Mrz―26 |
C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target? |
Mark B Pepys |
377 |
[GO] |
2021―Feb―05 |
Focus on atrial fibrillation, syncope, and arrhythmias during COVID-19 pandemic |
Filippo Crea |
378 |
[GO] |
2021―Feb―04 |
Cardiac arrest occurrence during successive waves of the COVID-19 pandemic: direct and indirect consequences |
Eloi Marijon, Nicole Karam, Xavier Jouven |
379 |
[GO] |
2020―Dez―10 |
Innovation in transforming a large-scale scientific medical conference in China entirely online in response to COVID-19 |
Jianping Li, Yuxi Li, Yong Huo |
380 |
[GO] |
2020―Nov―29 |
Rheumatic heart disease and COVID-19 |
Andrea Beaton, Liesl Zühlke, Jeremiah Mwangi, Kathryn A Taubert |
381 |
[GO] |
2020―Nov―28 |
Response to COVID-19 in a large academic Centre in South Africa |
Ntobeko A B Ntusi |
382 |
[GO] |
2020―Okt―30 |
COVID-19 pandemic: a sentiment analysis |
Ashish Kumar, Safi U Khan, Ankur Kalra |
383 |
[GO] |
2020―Okt―16 |
The effects of COVID-19 on general cardiology in Italy |
Carmen Anna Maria Spaccarotella, Salvatore De Rosa, Ciro Indolfi |
384 |
[GO] |
2020―Okt―12 |
The stethoscope: a potential vector for COVID-19? |
Rajiv S Vasudevan, Khalid Bin Thani, Dhuha Aljawder, Samantha Maisel, Alan S Maisel |
385 |
[GO] |
2020―Sep―18 |
Virtual medical education during the COVID-19 pandemic: how to make it work |
Amr Idris, Basel Edris |
386 |
[GO] |
2020―Sep―07 |
Collateral implications of the COVID-19 pandemic: belated presentation of infective endocarditis in a young patient |
Eva Toth, Luke Dancy, George Amin-Youssef, Alexandros Papachristidis, Rafal Dworakowski |
387 |
[GO] |
2020―Sep―03 |
Understanding COVID-19: in the end it is the endothelium-what else? |
Thomas F Lüscher |
388 |
[GO] |
2020―Jul―22 |
COVID-19 and cardiovascular disease |
Mark Nicholls |
389 |
[GO] |
2020―Jul―08 |
Acute coronary syndromes in developing countries during the COVID-19 pandemic |
Karim Said, Yasser El-Baghdady, Mohamed Abdel-Ghany |
390 |
[GO] |
2020―Jul―05 |
COVID-19 testing |
Roberto Ferrari, Marco De Angelis |
391 |
[GO] |
2020―Jun―20 |
Large intracardiac thrombus in a COVID-19 patient treated with prolonged extracorporeal membrane oxygenation implantation |
Dan Hu, Kan Liu, Bixi Li, Zhenhong Hu |
392 |
[GO] |
2020―Jun―17 |
EHRA 2020 during COVID-19 days |
Haran Burri, Katja Zeppenfeld, Hein Heidbuchel |
393 |
[GO] |
2020―Jun―17 |
Regulating drugs, medical devices, and diagnostic tests in the European Union: early lessons from the COVID-19 pandemic? |
Alan G Fraser, Piotr Szymański, Elizabeth Macintyre, Martin Landray |
394 |
[GO] |
2020―Jun―15 |
COVID-19 pandemic in India |
Venkata S Ram, Giridhara R Babu, Dorairaj Prabhakaran |
395 |
[GO] |
2020―Jun―14 |
COVID-19 and Katrina: recalcitrant racial disparities |
Harriette G C Van Spall, Clyde W Yancy, Keith C Ferdinand |
396 |
[GO] |
2020―Jun―08 |
The saga continues: is COVID-19 a cardiopulmonary disease? |
Thomas F Lüscher |
397 |
[GO] |
2020―Jun―06 |
COVID-19 and the healthcare workers |
Ankur Kalra, Erin D Michos, Kavitha M Chinnaiyan |
398 |
[GO] |
2020―Jun―03 |
Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs |
Luis M Ruilope, Juan Tamargo, Gema Ruiz-Hurtado |
399 |
[GO] |
2020―Mai―28 |
Czech Republic and low COVID-19 mortality in the heart of Europe: possible explanations |
Petr Widimsky, Jiri Benes, Alexander M Celko |
400 |
[GO] |
2020―Mai―25 |
Acute coronary syndromes during COVID-19 |
Serafina Valente, Francesca Anselmi, Matteo Cameli |
401 |
[GO] |
2020―Mai―25 |
Myocardial injury in severe COVID-19 infection |
Allan S Jaffe, John G F Cleland, Hugo A Katus |
402 |
[GO] |
2020―Mai―20 |
The ‘Black Death’ and the physician at the time of COVID-19 |
Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari |
403 |
[GO] |
2020―Mai―16 |
COVID-19: (mis)managing an announced Black Swan |
Thomas F Lüscher |
404 |
[GO] |
2020―Mai―14 |
Changes in the work mode of cardiologists during the COVID-19 epidemic in Wuhan |
Xiang Cheng, Changsheng Ma, Yaling Han |
405 |
[GO] |
2020―Mai―08 |
COVID-19 and congenital heart disease in perspective |
Michael A Gatzoulis |
406 |
[GO] |
2020―Mai―08 |
SARS-CoV-2, a novel virus with an unusual cardiac feature: inverted takotsubo syndrome |
Jorge Solano-López, Angel Sánchez-Recalde, José Luis Zamorano |
407 |
[GO] |
2020―Mai―07 |
TeleCheck-AF for COVID-19 |
Dominik Linz, Nikki A H A Pluymaekers, Jeroen M Hendriks |
408 |
[GO] |
2020―Mai―07 |
What COVID-19 is taking away from us |
Massimo Mapelli |
409 |
[GO] |
2020―Mai―07 |
Trying times for heart failure trials during the COVID-19 pandemic |
Judy Ozkan |
410 |
[GO] |
2020―Mai―07 |
The Certificate of Advanced Studies (CAS) course adapted to a pandemic |
Francesco Maisano, Agnes Bäker, Maurizio Taramasso, Barbara Jenny, Luca Vicentini, Victoria Jenkins, et al. (+4) Martin Andreas, Alberto Pozzoli, Michel Zuber, Carlos A Mestres |
411 |
[GO] |
2020―Mai―06 |
Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19 |
Gavin Y Oudit, Marc A Pfeffer |
412 |
[GO] |
2020―Mai―06 |
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy |
Riccardo M Inciardi, Marianna Adamo, Laura Lupi, Dario S Cani, Mattia Di Pasquale, Daniela Tomasoni, et al. (+16) Leonardo Italia, Gregorio Zaccone, Chiara Tedino, Davide Fabbricatore, Antonio Curnis, Pompilio Faggiano, Elio Gorga, Carlo M Lombardi, Giuseppe Milesi, Enrico Vizzardi, Marco Volpini, Savina Nodari, Claudia Specchia, Roberto Maroldi, Michela Bezzi, Marco Metra |
413 |
[GO] |
2020―Mai―06 |
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic |
Alaide Chieffo, Giulio G Stefanini, Susanna Price, Emanuele Barbato, Giuseppe Tarantini, Nicole Karam, et al. (+14) Raul Moreno, Gill Louise Buchanan, Martine Gilard, Sigrun Halvorsen, Kurt Huber, Stefan James, Franz-Josef Neumann, Helge Möllmann, Marco Roffi, Guido Tavazzi, Josepa Mauri Ferré, Stephan Windecker, Dariusz Dudek, Andreas Baumbach |
414 |
[GO] |
2020―Mai―06 |
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 |
Shaobo Shi, Mu Qin, Yuli Cai, Tao Liu, Bo Shen, Fan Yang, et al. (+7) Sheng Cao, Xu Liu, Yaozu Xiang, Qinyan Zhao, He Huang, Bo Yang, Congxin Huang |
415 |
[GO] |
2020―Apr―30 |
The battle against COVID-19: mortality in Italy |
Roberto Ferrari, Aldo P Maggioni, Luigi Tavazzi, Claudio Rapezzi |
416 |
[GO] |
2020―Apr―28 |
Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients? |
Ruihai Zhou |
417 |
[GO] |
2020―Apr―27 |
A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience |
Yaling Han |
418 |
[GO] |
2020―Apr―22 |
Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective |
Paul Carter, Michael Anderson, Elias Mossialos |
419 |
[GO] |
2020―Apr―18 |
Fulminant myocarditis in the time of coronavirus |
Vittoria Cuomo, Roberta Esposito, Ciro Santoro |
420 |
[GO] |
2020―Apr―15 |
Key words to be adopted for COVID-19 research |
Aldo Maggioni, Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari |
421 |
[GO] |
2020―Apr―13 |
Call to action for the cardiovascular side of COVID-19 |
Costanza Emanueli, Lina Badimon, Fabio Martelli, Ines Potočnjak, Irina Carpusca, Emma L Robinson, Yvan Devaux |
422 |
[GO] |
2020―Apr―13 |
Donning and doffing of personal protective equipment (PPE) for angiography during the COVID-19 crisis |
Thadathilankal-Jess John, Karim Hassan, Hellmuth Weich |
423 |
[GO] |
2020―Apr―13 |
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts |
Luka Nicin, Wesley Tyler Abplanalp, Hannah Mellentin, Badder Kattih, Lukas Tombor, David John, et al. (+8) Jan D Schmitto, Jörg Heineke, Fabian Emrich, Mani Arsalan, Tomas Holubec, Thomas Walther, Andreas M Zeiher, Stefanie Dimmeler |
424 |
[GO] |
2020―Apr―08 |
CAPACITY-COVID: a European registry to determine the role of cardiovascular disease in the COVID-19 pandemic |
Marijke Linschoten and, Folkert W Asselbergs |
425 |
[GO] |
2020―Apr―08 |
Priorities for Cath labs in the COVID-19 tsunami |
Gianluca Campo, Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari |
426 |
[GO] |
2020―Apr―08 |
Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage |
Bernhard Metzler, Peter Siostrzonek, Ronald K Binder, Axel Bauer, Sebastian Johannes Reinstadler |
427 |
[GO] |
2020―Apr―07 |
Transient complete heart block in a patient with critical COVID-19 |
Mona Azarkish, Vahideh Laleh far, Masoud Eslami, Reza Mollazadeh |
428 |
[GO] |
2020―Apr―07 |
Strategies to control COVID-19 and future pandemics in Africa and around the globe |
Anouar Fanidi, Xavier Jouven, Bamba Gaye |
429 |
[GO] |
2020―Apr―07 |
COVID-19 experience in Bergamo, Italy |
Michele Senni |
430 |
[GO] |
2020―Apr―07 |
Denominator matters in estimating COVID-19 mortality rates |
Bamba Gaye, Anouar Fanidi, Xavier Jouven |
431 |
[GO] |
2020―Apr―07 |
Typical takotsubo syndrome triggered by SARS-CoV-2 infection |
Philippe Meyer, Sophie Degrauwe, Christian Van Delden, Jelena-Rima Ghadri, Christian Templin |
432 |
[GO] |
2020―Apr―03 |
COVID-19-related myocarditis in a 21-year-old female patient |
In-Cheol Kim, Jin Young Kim, Hyun Ah Kim, Seongwook Han |
433 |
[GO] |
2020―Apr―01 |
The Cardiologist at the time of Coronavirus: a perfect storm |
Claudio Rapezzi, Roberto Ferrari |
434 |
[GO] |
2020―Mrz―31 |
Initial COVID-19 affecting cardiac patients in China |
Yaling Han |
435 |
[GO] |
2020―Mrz―30 |
Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by ‘on the scene’ cardiologists |
Lin Zhang, Yongzhen Fan, Zhibing Lu |
436 |
[GO] |
2020―Mrz―25 |
Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
Gian Battista Danzi, Marco Loffi, Gianluca Galeazzi, Elisa Gherbesi |
437 |
[GO] |
2020―Mrz―24 |
Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19 |
Alina Hua, Kevin O’Gallagher, Daniel Sado, Jonathan Byrne |
438 |
[GO] |
2020―Mrz―19 |
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? |
Gabriela M Kuster, Otmar Pfister, Thilo Burkard, Qian Zhou, Raphael Twerenbold, Philip Haaf, et al. (+2) Andreas F Widmer, Stefan Osswald |
439 |
[GO] |
2020―Mrz―13 |
Coronaviruses and the cardiovascular system: acute and long-term implications |
Tian-Yuan Xiong, Simon Redwood, Bernard Prendergast, Mao Chen |
440 |
[GO] |
2020―Mrz―06 |
Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin |
Hongde Hu, Fenglian Ma, Xin Wei, Yuan Fang |